Skip to main content
SpringerLink
Log in

Medizinische Behandlungsmaßnahmen

  • Chapter
Palliative Krebstherapie

  • 30 Accesses

Zusammenfassung

Ein maligner Primärtumor ist inkurabel, wenn er nicht entfernt oder seine Entfernung wegen der damit verbundenen Folgen nicht hingenommen werden kann und wenn es keine kurativ wirksame konservative Behandlung gibt. Die nichtchirurgische kurative Behandlung ist bis heute als alleinige Maßnahme nur bei wenigen Organtumoren möglich, so daß sich das Schicksal des Kranken meistens mit der Frage nach der chirurgischen Kurabilität entscheidet. Es lag nahe zu versuchen, durch möglichst weitgehende Radikalität des Eingriffs die Grenzen auszudehnen. Dieses Konzept hat für viele Tumoren enttäuscht und ist zum Teil wieder verlassen (z. B. Pankreaskarzinom, Rektumkarzinom, nach unserer Meinung Ösophaguskarzinom, gynäkologische Karzinome u. a.). Für verschiedene Geschwülste wurden kombinierte Schemata der primären Behandlung (Operation, Bestrahlung, Chemotherapie, Immuntherapie) entwickelt und dabei eine weniger radikale und weniger verstümmelnde Operation als Teil eingefügt (z. B. Analkarzinom, Extremitätensarkome, verschiedene kindliche Malignome wie Neuroblastome oder Wilms-Tumore, differenzierte Schilddrüsenkarzinome u.a.).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Adson MA (1987) Resection ofliver metastases - when is it worthwhile? World J Surg 11: 511

    PubMed  CAS  Google Scholar 

  2. Bross IDJ, Blumenson E (1976) Metastatic sites that produce generalized cancer: Identification and kinetics of generalized sites. In: Weiss L (ed) Fundamental aspects of metastasis. North-Holland, Amsterdam New York

    Google Scholar 

  3. Eder M (1987) In: Schildberg FW (Hrsg) Chirurgische Behandlung von Tumormetastasen. Melsungen, Medizinische Mitteilungen 58: 49

    Google Scholar 

  4. Eigler FW, Gross E, Heckemann R (1985) Wertigkeit der diagnostischen Verfahren und Nachsorgeprobleme bei lokalen und regionalen Tumorrezidiven im Gastrointestinaltrakt. Chirurg 56: 485

    PubMed  CAS  Google Scholar 

  5. Herfarth Ch, Schlag P, Hohenberger P (1985) Therapeutische Möglichkeiten bei locoregionären Rezidiven der Carcinome des Gastrointestinaltraktes. Chirurg 56: 492

    PubMed  CAS  Google Scholar 

  6. Junginger Th, Wahl W, Pichlmaier H (1989) Die chirurgische Behandlung des Magenfrühkarzinoms. Langenbecks Arch Chir 374: 175–180

    PubMed  CAS  Google Scholar 

  7. Keller R (1985) Surgical intervention and metastases. In: Metzger U, Largiadèr F, Senn HJ (eds) Perioperative chemotherapy. Springer, Berlin Heidelberg New York Tokyo (Recent results in cancer research, vol 98)

    Google Scholar 

  8. Kern KA, Pass HI, Roth JA (1987) Surgical treatment of pulmonary metastases. In: Rosenberg SA (ed) Surgical treatment of metastatic cancer. Lippincott, Philadelphia

    Google Scholar 

  9. Kinnaert P, Mahieu A, van Geertruyden M (1983) Effect of surgical trauma on delayed type hypersensitivity. J Surg Res 34: 227

    PubMed  CAS  Google Scholar 

  10. Liotta LA (1987) Overview of the biology of cancer invasion and metastases. In: Rosenberg SA (ed) Surgical treatment of metastatic cancer. Lippincott, Philadelphia

    Google Scholar 

  11. Löhrs U (1986) Heterogenität von Metastasen. In: Schildberg FW (Hrsg) Chirurgische Behandlung von Tumormetastasen. Melsungen, Medizinische Mitteilungen 58

    Google Scholar 

  12. Metzger U, Röthlin M, Largiadèr F (1988) Perioperative Chemotherapy bei gastrointestinalem Carcinom. Chirurg 59: 225

    PubMed  CAS  Google Scholar 

  13. Mountain CF (1977) A surgeon’s insight into tumor behavior. In: Williams TE, Wilson HE, Yohn DS (eds) Perspective lung cancer. Karger, Basel

    Google Scholar 

  14. Parrott NR, Lennard TWJ, Taylor RMR, Sehlton BK, Jonston IDA (1986) Effect of peri operative blood transfusion on recurrence of colorectal cancer. Br J Surg 73: 970

    PubMed  CAS  Google Scholar 

  15. Pichlmaier H, Grundmann R (1989) Transplantation and cancer. In: Veronesi U (ed) European Handbook of Surgical Oncology. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  16. Pichlmaier H (1988) Das kolorektale Karzinom. Arzt und Krankenhaus 5: 165–173

    Google Scholar 

  17. Raab M, Stützer H, Walgenbach S, Junginger Th (1985) Einfluß der chirurgischen Behandlungs-methode auf die Prognose des Magenfrühkarzinoms. Helv Chir Acta 52: 237–240

    PubMed  CAS  Google Scholar 

  18. Schildberg FW, Meyer G (1988) Palliative Operationsverfahren beim fortgeschrittenen Coloncarcinom. Chirurg 59: 625

    PubMed  CAS  Google Scholar 

  19. Shields TW (1977) Thoughts, concerning the management of patients with carcinoma of the lung. In: Williams TE, Wilson HE, Yohn DS (eds) Perspectives in lung cancer. Karger, Basel

    Google Scholar 

  20. Slade MS, Simmons RL, Eunice E, Greenberg LJ (1975) Immunodepression after major surgery in normal patients. Surgery 78: 363

    PubMed  CAS  Google Scholar 

  21. Tarpley JL, Twomey PL, Kattalona WJ, Chretian PD (1977) Suppression of cellular immunity by anesthesia and operation. J Surg Res 22: 195

    PubMed  CAS  Google Scholar 

  22. Vogt-Moykopf I, Branscheid D, Bülzebruck H, Probst G (1989) Aktuelle Aspekte der neuen Stadieneinteilung beim Bronchialcarcinom und ihre klinischen Konsequenzen. Chirurg 60: 16

    PubMed  CAS  Google Scholar 

  23. Weese JL, Ottery FD, Emoto SE (1986) Do operations facilitate tumor growth? An experimental model in rats. Surgery 100: 273

    PubMed  CAS  Google Scholar 

  24. Weiden PL, Beam MA, Shultz P (1987) Perioperative blood transfusion does not increase the risk of colorectal cancer recurrence. Cancer 60: 870

    PubMed  CAS  Google Scholar 

  25. Willig GW, Hajdu SI (1973) Histological benign teratoid metastasis of testicular embryonal carcinoma: report of five cases. Am J Chir Pathol 59: 338

    Google Scholar 

  26. Wilkens EW, Scanell JG, Graver JG (1978) Four decades of experience with resections for bronchogenic carcinoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg 76: 364

    Google Scholar 

  27. Ariyan S (1980) Pectoralis major, sternomastoid and other musculocutaneous flaps for head and neck reconstruction. Clin Plast Surg 7: 89

    PubMed  CAS  Google Scholar 

  28. Bakamjian VY, Long M, Rigg B (1971) Experience with the medially based deltopectoral flap in reconstructive surgery of the head and neck. Br J Plast Surg 24: 17406

    Google Scholar 

  29. Bekamjian VY, Cervino L, Miller S, Hentz VR (1973) The concept of cure and palliation by surgery in advanced cancer of the head and neck. Am J Surg 126: 482

    Google Scholar 

  30. Bertotti JA (1979) Trapezius musculocutaneous island flap in the repair of major head and neck cancer. Plast Reconstr Surg 65: 1

    Google Scholar 

  31. Breslow A (1970) Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172: 902

    PubMed  CAS  Google Scholar 

  32. Brones M F, Wheeler ES, Lesavoy MA (1982) Restoration of elbow flexion and arm contour with the latissimus dorsi myocutaneous flap. Plast Reconstr Surg 69: 329

    PubMed  CAS  Google Scholar 

  33. Caroll RE, Kleinmann WB (1979) Pectoralis major transplantation to restore elbow flexion to the paralytic limb. J Hand Surg (Br) 4: 501

    Google Scholar 

  34. Chicarilli ZN, Ariyan S, Cuono CB (1986) Single stage repair of complex scalp and cranial defects with free radial forearm flap. Plast Reconstr Surg 77: 577

    PubMed  CAS  Google Scholar 

  35. Conley J (1972) Use of composite flaps containing bone for major repairs in the head and neck. Plast Reconstr Surg 49: 22

    Google Scholar 

  36. Cuono CB, Ariyan S (1985) Versalility and safety of flap coverage for wide exzision of cutaneous melanoma. Plast Reconstr Surg 76: 28

    Google Scholar 

  37. Daniel RK (1973) Direct transfer of skin flaps by microvascular anastomoses. Masters thesis, McGill University Montreal

    Google Scholar 

  38. Daniel RK (1978) Mandibular reconstruction with free tissue transfers. Ann Plast Surg 1: 346

    PubMed  CAS  Google Scholar 

  39. Daniel RK, Kerrigan CL (1979) Skin flaps: An anatomical and hemodynamic approach. Clin Plast Surg 6: 181

    PubMed  CAS  Google Scholar 

  40. Dufresne C, Cutting C, Valauri F, Klein M, Colen S, McGarthy JG (1987) Reconstruction of mandibular and floor of mouth defects using the trapezius osteomyocutaneous flap. Plast Reconstr Surg 79: 687

    PubMed  CAS  Google Scholar 

  41. Donski PK, Buechler U, Tschopp HM (1982) Surgical dissection of the fibula for free microvascular transfer. Chir Plast 6: 15

    Google Scholar 

  42. Elder DE, Heiberger RM, LaRossa D et al. (1983) Optimal resection margin for cutaneous malignant melanoma. Plast Reconstr Surg 71: 66

    PubMed  CAS  Google Scholar 

  43. Hentz VR, Pearl RM (1983) The irreplaceable free flap: Skeletal reconstruction by microvascular free bone transfer. Ann Plast Surg 10: 36

    PubMed  CAS  Google Scholar 

  44. Hester TR, McConnel FM, Nahai F, Jurkiewicz MJ, Brown RG (1980) Reconstruction of esophagus, hypopharynx, and oral cavity using free jejunal transfer. Am J Surg 140: 487

    PubMed  CAS  Google Scholar 

  45. Hodges P, Tebbetts JB (1984) Principles of flaps. Selected readings. Plast Reconstr Surg 3: 1

    Google Scholar 

  46. Lang NP, Stair JM, Degges RD, Thompson C, Garner M, Baker GF, Westbrook KC (1984) Melanoma today does not require radical Surgery. Am J Surg 149: 723

    Google Scholar 

  47. Larson DL (1985) What is the appropriate management of tissue extravasation by antitumor agents? Plast Reconstr Surg 5: 397

    Google Scholar 

  48. Latham WD (1966) Operative treatment for post radiation defects of the chest wall. Am Surg 32: 700

    PubMed  CAS  Google Scholar 

  49. Logan SE, Mathes SJ (1984) The use of a rectus abdominis myocutaneous flap to reconstruct a groin defect. Br J Plast Surg 37: 351

    PubMed  CAS  Google Scholar 

  50. Longmire WP jr (1947) A modification of the Roux technique for antethoracic esophageal reconstruction - Anastomosis of the mesenteric and internal mammary blood vessels. Surgery 22: 94

    PubMed  Google Scholar 

  51. McCarthy JG, Haagensen CD, Herter FP (1974) The role of groin dissection in the management of melanoma of the lower extremity. Ann Surg 179: 156

    PubMed  CAS  Google Scholar 

  52. McGovern VJ, Shaw HM, Milton GW, Farago GA (1979) Prognostic significance of the histological features of malignant melanoma. Histopathology 3: 385

    PubMed  CAS  Google Scholar 

  53. McGregor JC, Palmer JH (1985) A critical review of flap repairs in the lower limb - One unit’s experience over the past five years. Chir Plastica 8: 95

    Google Scholar 

  54. Nozaki M, Huang TT, Hayashi M, Endo M, Hirayama T (1985) Reconstruction of the pharyngoesophageous following pharyngoesophagectomy and irradiation therapy. Plast Reconstr Surg 76: 386

    PubMed  CAS  Google Scholar 

  55. Olivari N (1976) The latissimus flap. Br J Plast Surg 29: 126

    PubMed  CAS  Google Scholar 

  56. Ostrup LT, Fredrickson JM (1975) Reconstruction of mandibular defects after irradiation using free living bone grafts by microvascular anastomoses. Plast Reconstr Surg 55: 563

    PubMed  CAS  Google Scholar 

  57. Ponten B (1981) The fasciocutaneous flap: its use in soft tissue defects of the lowerleg. Br J Plast Surg 34: 215

    PubMed  CAS  Google Scholar 

  58. Pitt TTE (1980) Aspects of surgical treatment for malignant melanoma. Clin Exp Dermatol 5: 313

    Google Scholar 

  59. Radovan C (1984) Tissue expansion in soft-tissue reconstruction. Plast Reconstr Surg 74: 482

    PubMed  CAS  Google Scholar 

  60. Rees RS, Ivey GL, Shack BR, Franklin JD, Lynch JB (1986) Pectoralis major musculocutaneous flaps: Long-term follow-up of hypopharyngeal reconstruction. Plast Reconstr Surg 77: 586

    PubMed  CAS  Google Scholar 

  61. Roberts RE, Douglass FM (1961) Replacement of the cervical esophagus and hypopharynx by a revascularized free jejunal autograft. N Engl J Med 264: 342

    PubMed  CAS  Google Scholar 

  62. Roses DF, Harris MN, Rigel D, Carrey Z, Friedman R, Kopf AW (1983) Local and intransit metastasis following definitive excision for primary cutaneous malignant melanoma. Ann Surg 98: 65

    Google Scholar 

  63. Rovira-Vila R, Ferreira BJ, Guinot A (1985) Transfer of vascularized extensor tendons from the foot to the hand with a dorsalis pedis flap. Plast Reconstr Surg 76: 421

    Google Scholar 

  64. Soutar DS, Scheker LR, Tanner NSB, McGregor IA (1983) The radial forearm flap: a versatile method for intraoral reconstruction. Br J Plast Surg 36: 1

    PubMed  CAS  Google Scholar 

  65. Swartz WM, Banis JC, Newton DN, Ramasastry SS, Jones NF, Acland R (1986) The osteocutaneous scapular flap for mandibular and maxillary reconstruction. Plast Reconstr Surg 77: 530

    PubMed  CAS  Google Scholar 

  66. Tansini I (1906) Sopra iI mio nuovo processo di amputazione della mammaella. Gazz Med Ital 57: 141

    Google Scholar 

  67. Taylor GI, Daniel RK (1973) The free flap: Composite tissue transfer by vascular anastomosis. Aust NZ J Surg 31: 17

    Google Scholar 

  68. Taylor GI., Corlett RJ, Boyd JB (1984) The versatile deep inferiorepigastric (inferior rectus abdominis) flap. Br J Plastic Surg 37: 330

    CAS  Google Scholar 

  69. Tizian C, Borst HG, Berger A (1985) Treatment of total sternal necrosis using the latissimus dorsi muscle flap. Plast Reconstr Surg 76: 703

    PubMed  CAS  Google Scholar 

  70. Treidman L, McNeer G (1963) Prognosis with local metastasis and recurrence in malignant melanoma. Ann NY Acad Sci 100: 123

    PubMed  CAS  Google Scholar 

  71. Wei FG, Chen HC, Chuang CC, Noordhoff SM (1986) Fibular osteoseptocutaneous flap: Anatomic study and clinical application. Plast Reconstr Surg 78: 191

    PubMed  CAS  Google Scholar 

  72. Zuker RM, Manktelow RT (1986) The dorsalis pedis free flap: Technique of elevation, foot closure, and flap application. Plast Reconstr Surg 77: 93

    PubMed  CAS  Google Scholar 

  73. Baumgartner-Ritter R (1981) Orthesen. In: Witt AN, Rettig H, Schlegel KF, Hackenbroch M, Hupfauer W (Hrsg) Orthopädie in Praxis und Klinik, Bd II. Thieme, Stuttgart

    Google Scholar 

  74. Hohmann D, Uhlig R (1982) Orthopädische Technik. Enke, Stuttgart

    Google Scholar 

  75. Jäger M, Wirth CJ (1986) Praxis der Orthopädie. Thieme, Stuttgart

    Google Scholar 

  76. Arlt B, Graßhoff H, Strelow M (1986) Die palliative Infrarot-Kontakt-Coagulation beim tiefsitzenden Rektumcarcinom. Chirurg 57: 469

    PubMed  CAS  Google Scholar 

  77. Bueß G, Theiß R, Günter M, Hutterer F, Hepp M, Pichlmaier H (1984) Endoskopische Operationen zur Polypabtragung im Rektum. Coloproctology 5: 254

    Google Scholar 

  78. Campbell WB (1987) Transanal resection in the palliation of rectal cancer. Ann Acad Med 16: 466

    CAS  Google Scholar 

  79. Eisenstat TE, Deak ST, Rubin RJ (1982) Five year survival in patients with carcinoma of the rectum treated by electrocoagulation. Am J Surg 143: 127

    PubMed  CAS  Google Scholar 

  80. Fritsch A, Seidl W, Walzel C (1982) Palliative and adjunctive measures in rectal cancer. World J Surg 6: 569

    PubMed  CAS  Google Scholar 

  81. de Graaf PW, Roussel JG, Gortzak E (1985) Early stage rectal cancer: electrofulguration in comparison to abdominoperineal exstirpation or low-anterior resection. J Surg Oncol 29: 123

    PubMed  Google Scholar 

  82. Kurz KR, Reid Pitts W, Speer D (1988) Palliation of carcinoma of the rectum and pararectum using the urologic rectoscope. Surg Gynecol Obstet 166: 60

    PubMed  CAS  Google Scholar 

  83. Mathus-Vliegen EMH, Tytgat GNJ (1986) Laser ablation and palliation in colorectal malignancy: results of a multicenter inquiry. Gastrointest Endosc 32: 393

    PubMed  CAS  Google Scholar 

  84. Pichlmaier H, Schildberg FW (1989) Thoracic surgery. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  85. Riemann JF, Mas R, Ginsbach Ch (1988) Palliative Lasertherapie fortgeschrittener Rektumkarzinome. Dtsch Med Wochenschr 113: 1057

    PubMed  CAS  Google Scholar 

  86. Salvati EP, Rubin RJ, Eisenstat TE (1988) Electrocoagulation of selected carcinoma of the rectum. Surg Gynecol Obstet 166: 393

    PubMed  CAS  Google Scholar 

  87. Weese JL, Bruskewitz RC (1984) Endoscopic transrectal resection of rectal carcinomas using the urologic rectoscope. Dis Colon Rectum 27: 123

    PubMed  CAS  Google Scholar 

  88. Bader M, Dittler HJ, Ultsch B, Ries G, Siewert JR (1986) Palliative treatment of malignant stenosis of the upper gastrointestinal tract using a combination of laser and afterloading therapy. Endoscopy 18: 27–31

    PubMed  Google Scholar 

  89. Cox J, Bennett JR (1987) Light at the end of the tunnel? Palliation for oesophageal carcinoma. Gut 28: 781–785

    PubMed  CAS  Google Scholar 

  90. Dumon JR, Reboud E, Garbe L, Aucomte F, Meric B (1982) Treatment of tracheobronchial lesions by laser photoresection. Chest 81: 278–284

    PubMed  CAS  Google Scholar 

  91. Dumon JF, Bourecerean J, Meric B, Jahjah F, Aucomte F, Dupin B (1983) Report of 100 Laser endobronchial resections. In: Joffe SN, Muckerheide MC, Goldman L (eds) Neodymium-YAG laser in medicine and surgery. Elsevier, New York, pp 59–69

    Google Scholar 

  92. Dumon JR, Shapshay S, Bourecerean J, Cavaliere S, Meric B, Garbi N et al (1984) Neodymium: YAG laser in bronchology. Chest 86: 163–168

    PubMed  CAS  Google Scholar 

  93. Eichenhorn MS, Kvale PA, Miks VM, Seydel HG, Horowitz B, Radke JR (1986) Initial combination therapy with YAG Laser photoresection and irradiation for inoperable non-small cell carcinoma of the lung. Chest 89: 782–785

    PubMed  CAS  Google Scholar 

  94. Einstein A (1917) Zur Quantentheorie der Strahlung. Phys Z 18: 121

    CAS  Google Scholar 

  95. Ell Ch, Riemann JF, Lux G, Demling L (1986) Palliative laser treatment of malignant stenoses in the upper gastrointestinal tract. Endoscopy 18: 21–26

    PubMed  Google Scholar 

  96. Fleischer D, Sivak M (1983) Recurrent gastric adenocarcinoma treated by endoscopic Nd:YAG laser therapy. Gastrointest Endosc 29: 161

    Google Scholar 

  97. Fleischer D, Kessler F, Hage O (1982) Endoscopic Nd:Y AG Laser therapy for carcinoma of the esophagus: A new palliative approach. Am J Surg 143: 280

    PubMed  CAS  Google Scholar 

  98. Gensic JE, Marcos HM, Uitert LG (1964) Laser oscillations in Nd-doped yttrium aluminium, yttrium gallium and gadolinium garnet. Appl Phys Lett 4: 182–184

    Google Scholar 

  99. Goodale RL, Okada A, Gozalez R (1970) Rapid endoscopic control of bleeding gastric erosions by laser radiation. Arch Surg 101: 211

    PubMed  CAS  Google Scholar 

  100. Kahida EF, Gordon FI, Miller RC (1965) Continuous duty argon ion lasers. IEEE J Quantum Electron I: 273–279

    Google Scholar 

  101. Kiefhaber P (1984) Indikationen für die endoskopische Verwendung des Lasers im Gastrointestinaltrakt. Münch Med Wschr 5: 103

    Google Scholar 

  102. Kiefhaber P, Nath G, Moritz K (1977) Endoscopical control of massive gastrointestinal hemorrhage by irradiation with a high-power Neodymium-Yag laser. Progr Surg 15: 140–150

    CAS  Google Scholar 

  103. Kiefhaber P, Moritz K, Heldwein W, Lehnert P, Weidinger P (1979) Endoskopische Blutstillung blutender Ösophagus- und Magenvarizen mit einem Hochleistungs Neodym YAG Laser. In: Demling L, Rösch W (Hrsg) Operative Endoskopie. Acrm, Berlin

    Google Scholar 

  104. Maiman TH (1960) Stimulated optical radiation in ruby. Nature 187: 493–494

    Google Scholar 

  105. Nath G, Gorisch W, Kiefhaber P (1973) First laser endoscopy via a fiberoptic transmission system. Endoscopy 5: 208–213

    Google Scholar 

  106. Nishioka NS, Jacques SL, Richter JM, Anderson RR (1988) Reflection and transmission of laser light from the esophagus: The influence of incident angle. Gastroenterology 94: 1180–1185

    PubMed  CAS  Google Scholar 

  107. Unger M, Atkinson G, William MD (1983) Nd:YAG Laser applications in pulmonary and endobronchiallesions. In: Joffe SN, Muckerheide MC, Goldman L (eds) Neodymium-YAG laser in medicine and surgery. Elsevier, New York, pp 71–81

    Google Scholar 

  108. Van Gossum A, Adler M, Des Marez B, Cemachovic I, Cremer M (1987) Endoscopic Nd-YAG laser therapy. A safe and effective form of palliative treatment for rectal adenocarcinoma. Acta Gastroenterol Belg 50: 218–224

    PubMed  Google Scholar 

  109. Wolfe WG, Cole PH, Sabiston DC (1984) Experimental and clinical use of the YAG laser in the management of pulmonary neoplasms. Am Surg 199: 526–531

    CAS  Google Scholar 

  110. Wolfe WG, Sabiston DC, Durham NC (1986) Management of benign and malignant lesions of the trachea and bronchi with the neodymium-yttrium-aluminium-garnet laser. J Thorac Cardiovasc Surg 91 : 40–45

    PubMed  CAS  Google Scholar 

  111. Ablin R (ed) (1980) Handbook of cryosurgery. Dekker, New York Basel

    Google Scholar 

  112. Chilla R, Opiatz M (1982) Die Bedeutung der Kryotherapie für die Behandlung benigner und maligner Mundschleimhautveränderungen. Rhinol Oto 161: 445

    Google Scholar 

  113. Cooper IS, Lee AS (1961) Cryostatic congelation: a system for producing a limited controlled region of cooling or freezing of biological tissues. J Nerv Ment Dis 133: 259

    PubMed  CAS  Google Scholar 

  114. Cooper IS, Hirose T (1966) Application of cryogenic surgery to resection of parenchymal organs. J Med 274: 15

    CAS  Google Scholar 

  115. Fritsch A, Seidl W, Walzel C, Moser K, Schiessel R (1982) Palliative and adjunctive measures in rectal cancer. World J Surg 6: 569

    PubMed  CAS  Google Scholar 

  116. Gage AA (1984) Cryosurgery for cancer. Compr Ther 10 (1): 61

    PubMed  CAS  Google Scholar 

  117. Heberer G, Deneke H, Demmel N, Wisching R (1987) Local procedures in the management of rectal cancer. World J Surg 11: 499

    PubMed  CAS  Google Scholar 

  118. Helpap B (1980) Der kryochirurgische Eingriff und seine Folgen. Thieme, Stuttgart New York

    Google Scholar 

  119. Kogel H, Willmen HR, Pichlmaier H, Junginger Th (1983) Kryotherapie des Mastdarmkrebses. Chir Praxis 31: 633

    Google Scholar 

  120. Kogel H, Grundmann R, Fohlmeister I, Pichlmaier H (1985) Zur Kryotherapie des Rektumkarzinoms. Zentralbl Chir 110: 147

    PubMed  CAS  Google Scholar 

  121. Langer S (1981) Kryo-Chirurgie. Langenbecks Arch Chir 355: 475

    PubMed  CAS  Google Scholar 

  122. Peitsch W, Schafmeyer A, Lange W (1988) Die Behandlung inoperabler Rektumkarzinome durch Kryochirurgie. Dtsch Ärztebl 85: 581

    Google Scholar 

  123. Reifferscheid M, Langer S (1980) Der Mastdarmkrebs. Schließmuskelerhaltende Therapieverfahren und ihre Indikationsgrenzen. Thieme, Stuttgart New York

    Google Scholar 

  124. Sommer J, Renziehausen K, Neuhauser H, Neuhauser M, Hecker J (1986) Möglichkeiten und Grenzen der Kryochirurgie des Vulvakarzinoms - 12jährige Therapieergebnisse. Zentralbl Gynäkol 108: 649

    PubMed  CAS  Google Scholar 

  125. Theiß R, Schmidt KH, Bueß G, Junginger Th (1985) Kryochirurgie beim inoperablen Rektumkarzinom. Zentralbl Chir 110: 142

    PubMed  Google Scholar 

  126. Walzel C (1978) Der heutige Stand der Kryochirurgie. Chirurg 49: 202

    PubMed  CAS  Google Scholar 

  127. Walzel C (1980) Kryochirurgie des Rektumkarzinoms. Krebsgeschehen, KIin Prax Onkol 3: 60

    Google Scholar 

  128. Zacarian SA (1985) Complications, indications and contraindications. Cryosurgery for skin cancer and cutaneous disorders. Mosby, St Louis, pp 283–297

    Google Scholar 

  129. Bader M, Dittler HJ, Ries G, Ultsch B, Lehr L, Siewert JR (1985) Endokavitäre Strahlentherapie in Afterloading-Technik bei malign en Stenosen des oberen Gastrointestinaltraktes und der Gallenwege. Leber Magen Darm 15: 247–255

    PubMed  CAS  Google Scholar 

  130. Heilmann H-P (Hrsg) (1985) Palliative Therapie. Zuckschwerdt, Munchen Bern Wien (Aktuelle Onkologie, Bd 23)

    Google Scholar 

  131. Kagan AR (1987) Radiotherapy management of metastasis. Refresher course. 29th Annual Scientific Meeting of the American Society for Therapeutic Radiology and Oncology, Boston/Mass. 18.-23.X.1987

    Google Scholar 

  132. Kagan AR (1987) Radiotherapeutic management of the patient for palliation. In: Perez CA, Brady LW (eds) Radiation oncology. Lippincott, Philadelphia

    Google Scholar 

  133. Kagan AR (1988) Dose-time relationship in the palliation of metastasis to liver, lung, brain and bone by radiation. Front Radiat Ther Oncol 22: 165–176

    PubMed  CAS  Google Scholar 

  134. Montague ED, De1clos L (1980) Palliative radiotherapy in the management of metastatic disease. In: Fletcher GH (ed) Textbook of radiotherapy, 3rd edn. Lea & Febiger, Philadelphia, pp 943–948

    Google Scholar 

  135. Richter MP, Coia LR (1985) Palliative radiation therapy. Semin Oncol 12: 375–383

    PubMed  CAS  Google Scholar 

  136. Rubin Ph, Salazar O, Zagars G, Constine LS, Keys H, Poulter CA, van Ess JD (1985) Systemic hemibody irradiation for overt and occult metastases. Cancer 55: 2210–2221

    PubMed  CAS  Google Scholar 

  137. Tepper JE, Wood WC, Cohen AM, Shipley WU, Orlow E, Hedberg SE, Warshaw AL et al. (1985) Intraoperative radiation therapy. In: deVita VT, Hellman S, Rosenberg SA (eds) Important advances in oncology. Lippincott, Philadelphia, pp 226–242

    Google Scholar 

  138. Aigner KR (1987) Isolated liver perfusion - pharmacokinetic considerations and clinical results. In: Aigner KR, Patt YZ (eds) Regional cancer treatment contributions to oncology. Karger, Basel

    Google Scholar 

  139. Austin EH, Wayne FM (1979) The treatment of recurrent malignant pleural effusion. Ann Thorac Surg 28: 190–203

    PubMed  CAS  Google Scholar 

  140. Beahrs OH, Sanfelippo PM (1971) Prognostic factors in carcinoma of the colon and rectum. Cancer 28: 213–217

    PubMed  CAS  Google Scholar 

  141. Bedikian AY (1983) Regional and systemic chemotherapy for advanced colorectal cancer - a review. Dis Colon Rectum 26: 327–332

    PubMed  CAS  Google Scholar 

  142. Beecham J, Blessing J, Creasman W, Hatch K (1987) Tamoxifen is effective as second line therapy for certain patients with advanced, chemotherapy-resistant epithelial ovarian cancer: a gynecologic oncology group study for 105 patients. Proc Am Soc Clin Oncol 7: 522

    Google Scholar 

  143. Beretta G, Labianca R, Locatell C et al. (1985) Epirubicin evaluation phase II-III studies at OSCB-Milan. Proc Am Soc Clin Oncol 4: 246

    Google Scholar 

  144. Bitrann JD, Desser RK, Kozloff MF et al. (1979) Treatment of metastatic adenocarcinoma of the pancreas with 5-fluorouracil, adriamycin and mitomycin C (FAM). Cancer Treat Rep 63: 2049–2051

    Google Scholar 

  145. Blumenreich MS, Yagoda A, Natale RB, Watson RC (1982) Phase II trial of vinblastine sulfate for metastatic urothelial tract tumors. Cancer 50: 435–441

    PubMed  CAS  Google Scholar 

  146. Brandes U, Israels LG (1982) Treatment of advanced plasma cell myeloma with weekly cyclophosphamide and alternate-day prednison. Cancer Treat Rep 66: 1413–1415

    PubMed  CAS  Google Scholar 

  147. Brenner DE (1986) Intraperitoneal chemotherapy: a review. J Clin Oncol 4: 1135–1147

    PubMed  CAS  Google Scholar 

  148. Brunner KW (1987) Palliative Tumor-Chemotherapie und Lebensqualität: was ist optimal? Schweiz Med Wochenschr 117: 688–692

    PubMed  CAS  Google Scholar 

  149. Buroker TR (1985) A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil in colorectal carcinoma. J Clin Oncol 3: 1624–1631

    PubMed  CAS  Google Scholar 

  150. Cullinan S, Moertel C, Fleming T et al. (1984) A randomized comparison of 5-FU alone (F), 5-FU + adriamycin (FA) and 5-FU + adriamycin + mitomycin-CX (FAM) in gastric and pancreatic cancer. Proc Am Soc Clin Oncol 3: 137

    Google Scholar 

  151. Cummings B, Keane T, Thomas G et al. (1984) Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy. Cancer 65: 2062–2068

    Google Scholar 

  152. DeHaes JCM, von Kippenberg CE (1985) The quality of life of cancer patients. A review of the literature. Soc Sci Med 20: 809–817

    PubMed  Google Scholar 

  153. DeVita VT (1986) Dose-response is alive and well. J Clin Oncol 4: 1157–1158

    Google Scholar 

  154. Ehrlichman C, Fine S, Wong A, Elhakim T (1988) A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma. J Clin Oncol 6: 469–475

    Google Scholar 

  155. Gastrointestinal Tumor Study Group (1982) Randomized study of combination chemotherapy in unresectable gastric cancer. Cancer 53: 13–17

    Google Scholar 

  156. Gralla RJ, Raphael BG, Young CW (1979) Phase II evaluation of vindesine in patients with nons mall cancer of the lung. Cancer Treat Rep 63: 1343–1346

    PubMed  CAS  Google Scholar 

  157. Gelber RD, Goldhirsch A (1986) A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. J Clin Oncol 4: 197–201

    Google Scholar 

  158. Gyves JW, Ensminger WD, Stetson P et al. (1984) Constant intraperitoneal 5-fluorouracil infusion through a totally implanted system. Clin Pharmacol Ther 35: 83–89

    PubMed  CAS  Google Scholar 

  159. Hakes TB, Chalas E, Saigo P, Geller N, Lewis JL (1987) Randomized prospective trial of cyclophosphamide, doxorubicin, and cisplatin (CAP) chemotherapy: 5 versus 10 cycles in stage III & IV ovarian carcinoma. Proc Am Soc Clin Oncol 6: 456

    Google Scholar 

  160. Hartlapp JH, Hollunder A (1987) Polychemotherapy for the treatment of extensive stage small cell lung cancer (SCLC). Proc Eur Conf Clin Oncol Cancer Nurs 4: 88

    Google Scholar 

  161. Hohn D, Stagg R, Friedman M, Ignoffo R, Rayner A, Hannigan J, Lewis B (1987) The NCOG randomized trial of intravenous vs. hepatic arterial FUDR for colorectal cancer metastatic to the liver. Proc Am Soc Clin Oncol 6: 333

    Google Scholar 

  162. Hortobagyi GN, Bodey GP, Buzdar AU et al. (1987) Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study. J Clin Oncol 5: 354–364

    PubMed  CAS  Google Scholar 

  163. Howell SB, Chu BB, Wung WE et al. (1981) Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions. J Clin Invest 67: 1161–1170

    PubMed  CAS  Google Scholar 

  164. Hryniuk W, Levine MN (1986) Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer. J Clin Oncol 4: 1162–1170

    PubMed  CAS  Google Scholar 

  165. Jenkins J, Sugarbaker P, Gianola F et al. (1982) Technical considerations in the use of intra peritoneal chemotherapy administered by Tenckhoff catheter. Surg Gynecol Obstet 154: 858–864

    PubMed  CAS  Google Scholar 

  166. Jarakousis CP (1982) Prednimustin in advanced soft tissue sarcomas. Cancer Treat Rep 66: 201–202

    Google Scholar 

  167. Kelsen D (1984) Chemotherapy of esophageal cancer. Semin Oncoll 1: 159–169

    Google Scholar 

  168. Kelsen D (1985) Chemotherapy of esophageal cancer. Eur J Cancer Clin Oncol 21: 5–7

    PubMed  CAS  Google Scholar 

  169. Klein HO, Wickramanayake PD, Farrokh G-R(1986) 5-fluorouracil (5-FU), adriamycin (ADM) and methotrexat (MTX) - a combination protocol (FAMTX) for metastasized stomach cancer. Proc Am Soc Clin Oncol 84: 825

    Google Scholar 

  170. Kolaric K (1983) Studies with epirubicin in gastric cancer. In: Bonadonna G (ed) Advances in anthracycline chemotherapy: epirubicin. Masson, Milan, pp 111–118

    Google Scholar 

  171. Kreuser ED (1985) Maligne Pleuraergüsse: Pathophysiologie, Diagnostik und Therapie. Dtsch Med Wochenschr 110: 1381–1386

    PubMed  CAS  Google Scholar 

  172. Krook JE, O’Connell MJ, Wieand HS (1988) Surgical adjuvant therapy of gastric cancer with doxorubicin and 5-fluorouracil. A joint Mayo Clinic / North Central Cancer Treatment Group study. Proc Am Soc Clin Oncol 7: 93

    Google Scholar 

  173. Kühnle H (1986) A phase II study of etoposide in advanced ovarian cancer with primary and secondary resistance to high dose cisplatin. Proc Am Assoc Cancer Res 27: 761

    Google Scholar 

  174. Labrie F, Dupont A, Belanger A (1985) Complete androgen blockade for the treatment of prostate cancer. In: DeVita VT, Hellman S, Rosenberg SA (eds) Important advances in oncology. Lippincott, Philadelphia, pp 193–217

    Google Scholar 

  175. Lober J, Mouridsen HT, Christiansen IE et al. (1983) A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer. Cancer 52: 1570–1575

    PubMed  CAS  Google Scholar 

  176. Machover D, Schwarzenberg L, Goldschmidt E (1982) Treatment of advanced colorectal and gastric adenocarcinoma with 5-FU combined with high-dose folinic acid: a pilot study. Cancer Treat Rep 66: 1803–1807

    PubMed  CAS  Google Scholar 

  177. Machover D, Goldschmidt E, Chollet P et al. (1986) Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J Clin Oncol 4: 685–696

    PubMed  CAS  Google Scholar 

  178. Mallinson CN (1980) Chemotherapy in pancreatic cancer: results of a controlled, prospective, multicenter trials. Br Med J 281: 1589–1591

    PubMed  CAS  Google Scholar 

  179. Malt RA (1983) Treatment of pancreatic cancer. JAMA 250: 1433–1443

    PubMed  CAS  Google Scholar 

  180. McDonald JS, Schein PS, Woolley PV (1980) 5-fluorouracil, doxorubicin, mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med 93: 533

    Google Scholar 

  181. McKelvey EM, Gottlieb JA, Wilson HE (1976) Hydroxydaunomycin combination chemotherapy in malignant lymphoma. Cancer 38: 1481–1488

    Google Scholar 

  182. Meyers FJ, Lewis B, Mitchell E et al. (1985) Phase II-trial of 4-epidoxorubicinin advanced colorectal carcinoma: a Northern California Oncology Group study. Cancer Treat Rep 69: 143–144

    PubMed  CAS  Google Scholar 

  183. Moertel CG (1984) Treatment of the carcinoid tumor and the malignant carcinoid syndrome. J Clin Oncol 1: 727–740

    Google Scholar 

  184. Myers C (1984) The use of intraperitoneal chemotherapy in the treatment of ovarian cancer. Semin Oncoll 1: 275–284

    Google Scholar 

  185. Natale RB, Yagoda A, Watson RC, Whitmore WF, Blumenreich M, Braun DW (1981) Methotrexate: an active drug in bladder cancer. Cancer 47: 1246–1250

    PubMed  CAS  Google Scholar 

  186. O’Connell MJ (1985) Current status of chemotherapy for advanced pancreatic and gastric cancer. J Clin Oncol 3: 1032–1039

    PubMed  Google Scholar 

  187. Petrelli N, Stablein D, Bruckner H et al. (1988) A prospective randomized phase III trial of 5-fluorouracil (5-FU) versus 5-FU + high dose leucovorin (HDCF) versus 5-FU + low dose leucovorin (LDCF) in patients with metastatic colorectal adenocarcinoma. A report of the gastrointestinal tumor study group. Proc Am Soc Clin Oncol 7: 94

    Google Scholar 

  188. Pfeifle CE, Howell SB, Markman M, Lucas W (1984) Totally implantable system for peritoneal access. J Clin Oncol 2: 1277–1280

    PubMed  CAS  Google Scholar 

  189. Rhomberg WU, Mesche E (1981) Vindesine in the treatment of advanced solid tumors. Experience with a twice weekly schedule. In: Brade W, Nagel GA, Seeber S (eds) Proceedings of the International Vinca Alkaloid Symposium - Vindesin. Karger, Basel, pp 222–226

    Google Scholar 

  190. Ross MB, Buzdar AV, Smith TL et al. (1985) Improved survival of patients with metastatic breast cancer receiving combination chemotherapy. Cancer 55: 341–346

    PubMed  CAS  Google Scholar 

  191. Schein PS (1985) The role of chemotherapy in the management of gastric and pancreatic carcinomas. Semin Onco1 12: 49–60

    CAS  Google Scholar 

  192. Sikic BI, Ballon SC, Suey L et al. (1986) Activity of high-dose megestrol acetate in patients with epithelial ovarian cancers refractory to chemotherapy. A phase II study of the Northern California Oncology Group. Proc Am Soc Clin Oncol 5: 477

    Google Scholar 

  193. Speyer JL, Collins JM, Dedrick RL et al. (1984) Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally. Cancer Res 40: 567–572

    Google Scholar 

  194. Tapazoglou E, Kish J, Ensley J, Al-Sarraf M (1986) The activity of a single-agent-5-fluorouracil infusion in advanced and recurrent head and neck cancer. Cancer 57: 1105–1109

    PubMed  CAS  Google Scholar 

  195. Ten Bokkel Huinink WW, Dubbelman R, Aartsen A et al. (1985) Experimental and clinical results with intraperitoneal cisplatin. Semin Oncol 12 [Suppl 4]: 43–46

    PubMed  Google Scholar 

  196. Valone FH, Drakes T, Flam M, Hannigan J (1988) Randomized trial of 5-FU vs.leucovorin plus 5-FU vs. sequential methotrexate, 5-FU, leucovorin in patients with advanced colorectal carcinoma. Proc Am Soc Clin Oncol 7: 95

    Google Scholar 

  197. Weiß J, Schmoll HJ (1984) Aminogluthetimid beim metastasierten Nebennierenkarzinom: Hochdosisbehandlung und Tachyphylaxie. In: Nagel GA, Schmidt-Matthiesen H, Drees N (Hrsg) Aminogluthetimid: ein Antiostrogen mit Aromatasehemmung. Zuckerschwerdt, München, S 152–156

    Google Scholar 

  198. Wils J, Bleiberg H, Blijham G et al. (1985) Phase II study of epirubicin in advanced adenocarcinoma of the pancreas. Eur J Cancer Clin Onco 121: 191–194

    Google Scholar 

  199. Zinser JW, Hortobagyi N, Buzdar A, Smith TL, Fraschini G (1987) Clinical course of breast cancer patients with liver metastases. J Clin Oncol 5: 773–782

    PubMed  CAS  Google Scholar 

  200. Aigner KR, Walther H, Tonn JC, Link KH, Schoch P, Schwemmle K (1984) Die isoJierte Leberperfusion bei fortgeschrittenen Metastasen kolorektaler Carcinome. Onkologie 7: 13

    PubMed  CAS  Google Scholar 

  201. Balch CM, Urist MM (1984) Intraarterielle Chemotherapie mit einer implantierbaren Infusionspumpe bei Lebermetastasen colorectaler Carcinome und Hepatomen. Chirurg 55: 485

    PubMed  CAS  Google Scholar 

  202. Bengtsson G, Carlsson G, Hafström L, Jönsson PE (1981) Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 141 : 586

    PubMed  CAS  Google Scholar 

  203. Cohen AM, Kaufmann SO, Wood WC (1985) Treatment of colorectal cancer hepatic metastases by hepatic artery chemotherapy. Dis Colon Rectum 28: 389

    PubMed  CAS  Google Scholar 

  204. Creech O, Krementz ET, Ryan RF (1958) Chemotherapy of cancer: Regional perfusion utilizing an extracorporeal circuit. Ann Surg 148: 616

    PubMed  Google Scholar 

  205. Ghussen F, Isselhard W (1984) The limit of hyperthermic strain on skeletal muscle tissue during regional perfusion. Res Exp Med 184: 115

    CAS  Google Scholar 

  206. Ghussen F, Nagel K, Isselhard W, Marx G, Wellart A, Müller EW (1982) Ein neues Verfahren zur isolierten regionalen Leberperfusion in vivo. Langenbecks Arch Chir 356: 251

    PubMed  CAS  Google Scholar 

  207. Hottenrott C, Nagel K, Lorenz M (1986) Regionale Chemotherapie der Leber und Extremitäten. Standortbestimmung. Kehrer, Freiburg

    Google Scholar 

  208. Huber R, Helling HJ, Groth W, Pichlmaier H (1990) 10 Jahre hypertherme Extremitätenperfusion - Ein Erfahrungsbericht. Zentralbl Chir 115: 578

    Google Scholar 

  209. Jacobs JU, Fexner JM, Scott HW (1961) Selective isolated perfusion of the right or left lung. J Thorac Cardiovasc Surg 42: 546

    PubMed  CAS  Google Scholar 

  210. Johnston MR, Minchin R, Shull JH, Thenot JP, Mc Manns BM, Terril R, Boyd MR (1983) Isolated lung perfusion with adriamycin. Cancer 52: 404

    PubMed  CAS  Google Scholar 

  211. Krementz ET (1986) Regional perfusion. Current sophistication, what next? Cancer 57: 416

    PubMed  CAS  Google Scholar 

  212. Kemeny MM, Goldberg D, Beatty D et al. (1986) Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer 57: 492

    PubMed  CAS  Google Scholar 

  213. Lahr CJ, Soong SJ, Cloud G, Smith J, Urist MM, Balch CM (1983) A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol 1: 720

    PubMed  CAS  Google Scholar 

  214. Niederhuber JE, Ensminger W, Gyves J, Thrall J, Walker S, Cozzi E (1984) Regional chemotherapy of colorectal cancer metastatic to the liver. Cancer 53: 1336

    PubMed  CAS  Google Scholar 

  215. Pierpont H, Blades B (1960) Lung perfusion with chemotherapeutic agents. J Thorac Cardiovasc Surg 39: 159

    PubMed  CAS  Google Scholar 

  216. Schraffordt-Koops H, Beekhuis H, Oldhoff J, Osterhuis JW, van der Ploog E, Vermey A (1981) Local recurrence and survival in patients with stage I malignant melanoma of the extremities after regional perfusion. Cancer 48: 1952

    PubMed  CAS  Google Scholar 

  217. Shepard KV, Levin B, Karl RC, Faintuch J, DuBrow RA, Hagle M, Cooper RM, Beschorner J, Stablein D (1985) Therapy for metastatic colorectal cancer with hepatic artery infusion chemotherapy using a subcutaneous implanted pump. J Clin Oncol 3: 161

    PubMed  CAS  Google Scholar 

  218. Shingleton WW, Parker RY, Mahaley S (1961) Abdominal perfusion of cancer chemotherapy with hypothermia and hyperthermia. Surgery 50: 260

    Google Scholar 

  219. Stehlin JS (1969) Hyperthermic perfusion with chemotherapy for cancers of the extremities. Surg Gynecol Obstet 129: 305

    PubMed  Google Scholar 

  220. Sugarbaker P, Chang AE, Schneider PhD, Simpson C, Culnane M, Steinberg SM (1988) A prospective randomized trial of regional versus systemic continuous 5-fluorodoxyuridine chemotherapy in the treatment of colorectalliver metastases. Workshop: Progress in Regional Chemotherapy I Wien, 3.-5. November.

    Google Scholar 

  221. Woodhall B, Hall K, Mahaley S, Jackson J (1959) Chemotherapy of brain cancer. Experimental and clinical studies in localized hypothermic brain perfusion. Ann Surg 150: 640

    PubMed  CAS  Google Scholar 

  222. Alavi JB, McLean GK (1983) Hypertension with renal carcinoma. An effect of arterial embolization. Cancer 52: 169–172

    PubMed  CAS  Google Scholar 

  223. Allison DJ, Jordan H, Hennessy O (1985) Therapeutic embolization of the hepatic artery: A review of 75 procedures. Lancet I: 595–599

    Google Scholar 

  224. Attali P, Houssin D, Roche A, Buffet C, Bismuth H, Etienne JP (1984) Hepatic arterial embolization for malignant hypercalcemia in hepatocellular carcinoma. Dig Dis Sci 29: 466–469

    PubMed  CAS  Google Scholar 

  225. Basche S, Leisering W, Kachel R (1988) Die Bedeutung der Embolisationstherapie für die Prognose des Nierenzellkarzinoms. In: Schneider GH, Vogler E (Hrsg) Digitale bildgebende Verfahren. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  226. Bechtel W, Wright KC, Wallace S, Mosier B, et al. (1986) An experimental evaluation of microcapsules for arterial chemoembolization. Radiology 161: 601–604

    PubMed  CAS  Google Scholar 

  227. Berenstein A, Kricheff II (1979) Catheter and material selection for transarterial embolization: Technical considerations. Radiology 132: 619–630

    PubMed  CAS  Google Scholar 

  228. Bono AV, Caresano A (1983) The role of embolization in the treatment of kidney carcinoma. Eur Uro1 9: 334–337

    CAS  Google Scholar 

  229. Braedel HU, Zwergel U, Knopp W (1984) Embolization of pelvic bone metastases from renal cell carcinoma. Eur Urol 10: 380–384

    PubMed  CAS  Google Scholar 

  230. Carrasco Ch, Soo CS, Chuang VP, Wallace S (1983) Transcatheter management of hepatic neoplasms. Appl Radiol 12: 47–48, 50, 52–54

    Google Scholar 

  231. Carroll BA, Walter JF (1983) Gas in embolized tumors: An alternate hypothesis for its origin. Radiology 147: 441–444

    PubMed  CAS  Google Scholar 

  232. Cataneda-Zuniga WR, Sanchez R, Amplatz K (1978) Experimental observations on short and long-term effects of arterial occlusion with ivalon. Radiology 126: 783–785

    Google Scholar 

  233. Cho KJ, Lunderquist A (1983) Experimental hepatic artery embolization with gelfoam powder. Invest Radiol 18: 189–193

    PubMed  CAS  Google Scholar 

  234. Chuang VP, Wallace S (1981) Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology 140: 51–58

    PubMed  CAS  Google Scholar 

  235. Chuang VP, Wallace S (1983) Interventional approaches to hepatic tumor treatment. Semin Roentgenol 18: 127–135

    PubMed  CAS  Google Scholar 

  236. Chuang VP, Wallace S, Soo CS, Charnsangavej C, Bowers T (1982) Therapeutic ivalon embolization of hepatic tumors. AJR 138: 289–294

    PubMed  CAS  Google Scholar 

  237. Clouse ME, Lee RGL, Duszlak EJ, Lokich JJ et al. (1983) Peripheral hepatic artery embolization for primary and secondary hepatic neoplasms. Radiology 147: 407–411

    PubMed  CAS  Google Scholar 

  238. Coldwell D, Roth H, Mortimer J, Press O, Nance D, Harley J, Goldman M (1988) Alternation in liver function tests after hepatic arterial embolization. Proc Annu Meet Am Soc Clin Oncol 7: A422

    Google Scholar 

  239. Coldwell DM, Hottenstein DW, Ricci JA, Wengert PA (1985) Emphysematous cholecystitis as a complication of hepatic arterial embolization. Cardiovasc Intervent Radiol 8: 36–38

    PubMed  CAS  Google Scholar 

  240. Cox GG, Lee KR, Price HI, Gunter K, Noble MJ, Mebust WK (1982) Colonic infarction following ethanol embolization of renal-cell carcinoma. Radiology 145: 343–345

    PubMed  CAS  Google Scholar 

  241. Doppman JL, Girton M, Vermess M (1982) The risk of hepatic artery embolization in the presence of obstructive jaundice. Radiology 143: 37–43

    PubMed  CAS  Google Scholar 

  242. Doppman JL, Girton ME (1984) Bile duct scarring following ethanol embolization of the hepatic artery: An experimental study in monkeys. Radiology 152: 621–626

    PubMed  CAS  Google Scholar 

  243. Ekelund L, Karp W, Mansson W, Olsson AM (1981) Palliative embolization of renal tumors: follow-up of 19 cases. Urol Radiol 3: 13–18

    PubMed  CAS  Google Scholar 

  244. Furui S, Otomo K, Itai Y, lio M (1984) Hepatocellular carcinoma treated by trans catheter arterial embolization: Progress evaluated by computed tomographie. Radiology 150: 773–778

    PubMed  CAS  Google Scholar 

  245. Gianturco C, Anderson JH, Wallace S (1975) Mechanical devices for arterial occlusion. AJR 124: 428–435

    CAS  Google Scholar 

  246. Goldman ML, Philip PK, Sarrafizadeh MS (1984) Bucrylate, a liquid tissue adhesive for traoscatheter embolization. Appl Radiol: 89–94

    Google Scholar 

  247. Jaschke W, Hoevels J (1988) Control of hepatic tumor hemorrhage by transcatheter embolization with Ethibloc. Acta Radiol 29: 15–19

    PubMed  CAS  Google Scholar 

  248. Junyuan G, Zhicheng H, Pengcheng L, Daoyu H (1987) Intraarterielle Chemotherapie und Embolisierung der Arteria hepatica bei primären Lebercarcinomen. Röntgenpraxis 40: 211–214

    Google Scholar 

  249. Kato T, Nemoto R, Mori H, Takahashi M et al. (1981) Arterial chemoembolization with mitomycin C microcapsules in the treatment of primary or secondary carcinoma of the kidney, liver, bone and intrapelvic organs. Cancer 48: 674–680

    PubMed  CAS  Google Scholar 

  250. Kauffmann GW, Rohrbach R, Richter G, Rossweiler J, Sommerkamp H (1984) Nierentumorembolisation. Fortschritte, Erfahrungen und Komplikationen. Urologe 23: 109–116

    PubMed  CAS  Google Scholar 

  251. Kaufmann G, Richter G (1988) Embolisationsmaterialien. In: Günther R, Thelen M (Hrsg) Interventionelle Radiologie. Thieme, Stuttgart

    Google Scholar 

  252. Kaufmann G, Richter G (1988) Embolisation der Niere. In: Günther R, Thelen M (Hrsg) Interventionelle Radiologie. Thieme, Stuttgart

    Google Scholar 

  253. Kim Th, Chuang V, Ricketts R, Zaatari G et al. (1986) Improved surgical resectability of childhood hepatic malignancies by primary transcatheter embolization. Proc Am Soc Clin Onool 5: 203

    Google Scholar 

  254. Klose KJ, Thelen M, Günther R, Wanek R (1981) Transcatheter embolization in pelvic malignancy. A summary of 26 cases. Ann Radiol 24: 390–393

    PubMed  CAS  Google Scholar 

  255. Lammer J, Justich E, Schreyer H, Ebner F (1983) Therapeutische Embolisation mit Polyvinylalkohol (Ivalon). Klinische Erfahrungen. Röntgenblätter 36: 152–157

    Google Scholar 

  256. Lammer J, Justich E, Schreyer H, Pettek R (1985) Complications of renal tumor embolization. Cardiovasc Intervent Radiol 8: 31–35

    PubMed  CAS  Google Scholar 

  257. Lang EK (1984) Transcatheter embolization of renal tumors with 1–124 particies. Digitale Bilddiagn 4: 165–170

    PubMed  CAS  Google Scholar 

  258. Lasjaunias P (1980) Nasopharyngeal angiofibromas: Hazards of embolization. Radiology 136: 119–123

    PubMed  CAS  Google Scholar 

  259. Löhr E, Ross S (1985) Embolisationstherapie von Nierentumoren-Erfahrungen an einem Krankengut von 60 Patienten. Radiologe 25: 354–358

    PubMed  Google Scholar 

  260. Löhr E, Schmitt-Neuerburg P, Heckemann R (1985) Embolisationstherapie von primären Weichteiltumoren und metastatischen Raumforderungen im Beckenbereich. Radiologe 25: 359–363

    PubMed  Google Scholar 

  261. Martensson H, Nobin A, Bengmark S, Lunderquist A, Owman T, Sanden G (1984) Embolization of the liver in the management of metastatic carcinoid tumors. J Surg Onco 127: 152–158

    Google Scholar 

  262. Marx FJ, Chaussy C, Moser E (1982) Grenzen und Gefahren der palliativen Embolisation inoperabler Nierentumoren. Urologe (Aus. A) 21: 206–210

    CAS  Google Scholar 

  263. Mathias K, Löffler T, Hoffmann G, Hausamen T (1986) Radiologischer Beitrag zur Behandlung primärer und sekundärer Lebertumoren. Radiologe 26: 129–136

    PubMed  CAS  Google Scholar 

  264. Mazer MJ, Baltaxe HA, Wolf GL (1981) Therapeutic embolization of the renal artery with Gianturco coils: limitations and technical pitfalls. Radiology 138: 37–46

    PubMed  CAS  Google Scholar 

  265. Milewski JB, Malewski AW, Malanowska S, Borkowski A, Skowronski IA, Tomankiewicz Z, Sawicka E (1981) Spinal cord damage as a complication of renal artery embolization in patients with renal carcinoma. Int Urol Nephrol 13: 221–229

    PubMed  CAS  Google Scholar 

  266. Mitty HA, Warner RRP, Newman LH, Train JS et al. (1985) Control of carcinoid syndrome with hepatic artery embolization. Radiology 155: 623–626

    PubMed  CAS  Google Scholar 

  267. Nakamura H, Hashimoto T, Oi H, Sawada S (1987) Hepatic embolization through periportal collaterals: Balloon occlusion technique. AJR 148: 626–628

    PubMed  CAS  Google Scholar 

  268. Nakamura H, Hashimoto T, Oi H, Sawada S (1988) Iodized oil in the portal vein alter arterial embolization. Radiology 167: 415–417

    PubMed  CAS  Google Scholar 

  269. Nakao N, Miura K, Takahashi H, Ohnishi M et al. (1986) Hepatocellular carcinoma: Combined hepatic, arterial, and portal venous embolization. Radiology 161: 303–307

    PubMed  CAS  Google Scholar 

  270. Nemoto R, Kato T, Iwata K, Mori H, Takahashani M (1981) Evaluation of therapeutic arterial embolization in renal cell carcinoma using microencapsulated mitomycin C. Urology 17: 315–319

    PubMed  CAS  Google Scholar 

  271. Ohishi H, Uchida H, Yoshimura H, Ohue S et al. (1985) Hepatocellular carcinoma detected by iodized oil. Radiology 154: 25–29

    PubMed  CAS  Google Scholar 

  272. Patt YZ, Chuang VP, Wallace S, Hersh EM et al. (1981) The palliative role of hepatic arterial infusion and arterial occlusion in colorectal carcinoma metastatic to the liver. Lancet: 349–350

    Google Scholar 

  273. Pfeifer KJ, Eibl-Eibesfeldt B, Huber RM, Kenn RW, Mangel E, Mayr B (1988) Mikroembolisation von Lebermetastasen. In: Schneider GH, Vogler E (Hrsg) Digitale bildgebende Verfahren. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  274. Powell-Tuck J, Mcivor J, Reynolds KW, Murray-Lyon IM (1984) Prediction of early death after therapeutic hepatic arterial embolization. Br Med J (Clin Res) 288: 1257–1259

    CAS  Google Scholar 

  275. Quinn MF, Lundell CJ, Daniels JR, Vegh GB, Engelson ET (1988) Transpancreatic catheterization of the right hepatic artery for chemoembolization using a new infusion system. Cathet Cardiovasc Diagn 14: 115–117

    PubMed  CAS  Google Scholar 

  276. Remy J, Arnaud A, Fardou H, Giraud R, Voisin C (1977) Treatment of hemoptysis by embolization of bronchial arteris. Radiology 122: 33–37

    PubMed  CAS  Google Scholar 

  277. Richter GM, Kauffmann GW, Wimmer B (1985) Die kapilläre Embolisation des blutenden Nierentumors. Ein ungewöhnlicher Fallbericht. Radiologe 25: 364–370

    PubMed  CAS  Google Scholar 

  278. Schild H (1988) Embolisation der Leber. In: Gunther R, Thelen M (Hrsg) Interventionelle Radiologie. Thieme, Stuttgart

    Google Scholar 

  279. Schoenemann B (1981) Anomalien der Arterien im Oberbauch und ihre chirurgische Relevanz. Inaugural-Dissertation, Med. Fakultät, Universitat Köln

    Google Scholar 

  280. Schultheis KH (1985) Embolisation - Chemoembolisation. Beitr Onkol 21: 201–228

    Google Scholar 

  281. Seifart W, Waigand J, Booss HJ, Slisow W, Uhlig F (1986) Chemoembolisation der A. hepatica kombiniert mit intraportaler Zytostatikum-Infusion. Ein neues Konzept für die regionale Chemotherapie von Lebermetastasen. Arch Geschwulstforsch 56: 445–450

    PubMed  CAS  Google Scholar 

  282. Stoesslein F, Ditscherlein G, Romaniuk PA (1982) Experimental studies on new liquid embolization mixtures (Histoacryl-Lipiodol, Histoacryl-Panthopaque). Cardiovasc Intervent Radiol 5: 264–267

    PubMed  CAS  Google Scholar 

  283. Suzuki K, Kono N, Ono A, Osuga Y et al. (1988) Transcatheter arterial chemo-embolization for humoral hypercalcemia of hepatocellular carcinoma. Gastroenterol Jpn 23: 29–36

    PubMed  CAS  Google Scholar 

  284. Takayasu K, Moriyama N, Muramatsu Y, Suzuki M et al. (1984) Hepatic arterial embolization for hepatocellular carcinoma. Radiology 150: 661–665

    PubMed  CAS  Google Scholar 

  285. Takayasu K, Moriyama N, Muramatsu Y, Suzuki M et al. (1984) Splenic infarction, a complication of trans catheter hepatic arterial embolization for liver malignancies. Radiology 151: 371–375

    PubMed  CAS  Google Scholar 

  286. Toelle E, Cramer BM (1983) K1inische Erfahrungen mit der arteriellen Embolisation von Nierentumoren mit Äthanol. Urologe [A] 22: 208–212

    Google Scholar 

  287. Triller J, Schröder R (1985) Perkutane intraarterielle Infusion und Embolisation von Lebermetastasen kolorektaler Karzinome. Fortschr Röntgenstr 143: 307–315

    CAS  Google Scholar 

  288. Tylen U, Dah E, Fredlund P (1981) Angiography after temporary inhibition of blood flow followed by intraarterial 5-fu infusion in the treatment ofliver metastases. Acta Radiol 22: 15–23

    CAS  Google Scholar 

  289. Varna J, Huben RP, Wajsman Z, Pontes JE (1984) Therapeutic embolization of pelvic metastases of renal cell carcinoma. J Urol 131: 647–649

    Google Scholar 

  290. Vogelsang H, Schmidt RC (1980) Therapeutische Embolisation von kraniofazialen und spinalen Gefäßfehlbildungen sowie von Gefäßtumoren. Dtsch Aerztebl 14: 881–886

    Google Scholar 

  291. Wallace S, Chuang VP, Swanson D, Bracken B, Hersh EM, Ayala A, Johnson D (1981) Embolization of renal carcinoma. Radiology 138: 563–570

    PubMed  CAS  Google Scholar 

  292. Wallace S, Charnsangavej, Ch, Carrasco CH, Bechtel W (1984) Ethanol for hepatic artery embolization. Radiology 152: 821–822

    PubMed  CAS  Google Scholar 

  293. Weber J, Kaufmann J, Kult K (1984) Palliative Nierentumorembolisation mittels Jodoel-markiertem Ethibloc. Fortschr Röntgenstr 141: 384–389

    CAS  Google Scholar 

  294. White RI, Kaufmann SL, Barth KH, DeCaprio V et al. (1979) Embolotherapy with detachable silicone balloons. Radiology 131: 619–627

    PubMed  Google Scholar 

  295. Wilner HI, Lazo A, Metes JJ, Beil KA et al. (1987) Embolization in cataclysmal hemorrhage caused by squamous cell carcinomas of the head and neck. Radiology 163: 759–762

    PubMed  CAS  Google Scholar 

  296. Yamada R, Sato M, Kawabata M, Kakatsuka H, Nakamura K, Takashima S (1983) Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 148: 397–401

    PubMed  CAS  Google Scholar 

  297. Zollikofer Ch, Castaneda-Zuniga WR, Galliani C, Rysavy JA et al. (1980) Therapeutic blockade of arteries using compressed ivalon. Radiology 136: 635–640

    PubMed  CAS  Google Scholar 

  298. Aggarwal BB, Eessalu TE, Hass PE (1985) Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon. Nature 318: 665

    PubMed  CAS  Google Scholar 

  299. Agnantis NJ, Spandidos DA (1988) Immunohistochemical analysis of ras and c-myc oncoproteins in human lesions of breast, uterus and colon. Abstracts of the Second International Conference of Anticancer Research, Saronis/Greece, Abstr No 270, p 1102

    Google Scholar 

  300. Balkwill FR, Smyth JF (1987) Interferons in cancer therapy: a reappraisal. Lancet II: 317

    Google Scholar 

  301. Balkwill F, Burke F, Talbot D, Tavernier J, Osborne R, Naylor St, Durbin H, Fiers W (1987) Evidence for tumour necrosis factor/ cachectin production in cancer. Lancet II: 1229

    Google Scholar 

  302. Beaupain R, Billard C, Falcoff E (1986) Effects of human recombinant interferons-α2, -β and-γ on growth and survival of human cancer nodules maintained in continuous organotypic culture. Eur J Cancer Clin Oncol 22: 141

    PubMed  CAS  Google Scholar 

  303. Berd D, Mastrangelo MJ (1987) Elimination of immune suppressor mechanisms in humans by oxazaphosphorines. Methods Find Exp Clin Pharmacol 9: 569

    PubMed  CAS  Google Scholar 

  304. Boraschi D, Tagliabue A (1984) Multiple modulation of macrophage functions by lymphokines: different effects of interferon and macrophage activating factor. Lymphokines 9: 71

    CAS  Google Scholar 

  305. Boraschi D, Soldateschi D, Tagliabue A (1982) Macrophage activation by interferon: dissociation between tumorcidal capacity and supressive activity. Eur J Immunol 12: 320

    PubMed  CAS  Google Scholar 

  306. Boraschi D, Censini S, Bartalini M, Scapigliati G, Barbarulli G, Vicenzi E, Donati MB, Tagliabue A (1984) Interferon inhibits prostaglandin biosynthesis in macrophages: effects on arachidonic acid metabolism. J Immunol 132: 1987

    PubMed  CAS  Google Scholar 

  307. Boraschi D, Censini S, Tagliabue A (1984) Interferon-γ reduces macrophage suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production. J Immunol 133: 764

    PubMed  CAS  Google Scholar 

  308. Boraschi D, Censini S, Bartalani M, Tagliabue A (1985) Regulation of arachidonic acid metabolism in macrophages by immune and nonimmune interferons. J Immunol 135–502

    Google Scholar 

  309. Buckle AM, Potter CW, Rees RC, Rogers K, Jacob G (1988) HLA antigen expression in colon carcinoma cells. Abstracts of the Second International Conference of Anticancer Research, Saronis/Greece, Abstr No 269, p 1102

    Google Scholar 

  310. Burger CJ, Elgert KD, Farrar WL (1984) Interleukin 2 (IL-2) activity during tumor growth: IL-2 production, kinetics, absorption of and responses to exogenous IL-2. Cell Immunol 84: 228

    PubMed  CAS  Google Scholar 

  311. Cianciolo G, Hunter J, Silva J, Haskill JS, Snyderman R (1981) Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15 (E) structural protein of retroviruses. J Clin Invest 68: 831

    PubMed  CAS  Google Scholar 

  312. Clercq E de, Zhang ZX, Huygen K (1982) Synergism in the antitumor effects of type I and type II interferon in mice inoculated with leukemia L1210 cells. Cancer Lett 15: 223

    PubMed  Google Scholar 

  313. Cochran AJ, Wen DR, Fanad Z, Stene MA, Lana AMA, Hoon DSB, Morton DL (1988) Immune suppression by melanoma cells as a factor in the generation of metastatic disease. Abstracts of the Second International Conference of Anticancer Research, Saronis/Greece, Abstr No 369, p 1130

    Google Scholar 

  314. Cunningham-Rundles S, Filippa DA, Braun OW Jr, Antonelli P, Ashikari H (1981) Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women. JNCI 67: 585

    PubMed  CAS  Google Scholar 

  315. Czarniecki CW, Fennie CW, Powers DB, Estell DA (1984) Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons. J Virol 49: 490

    PubMed  CAS  Google Scholar 

  316. Davies P, Bonney RJ, Humes JL, Kuehl FA jr (1980) The synthesis of arachidonic acid oxygenation products by various mononuclear phagocyte populations. In: Furth R van (ed) Mononuclear phagocytes. Functional aspects. Nijhoff, The Hague, p 1317

    Google Scholar 

  317. Dean RT, Virelizier JL (1983) Interferon as a macrophage activating factor. I Enhancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals. Clin Exp Immunol 51: 501

    PubMed  CAS  Google Scholar 

  318. Deodhar SC, Crile G, Esselstyn CB jr (1972) Study of the tumor cell-lymphocyte interaction in patients with breast cancer. Cancer 29: 132

    Google Scholar 

  319. Didier M (1987) Abstrakt auf dem gemeinsamen Kongreß der Schweizerischen und Französischen Gesellschaften für Allerlogie und Immunologie in Genf

    Google Scholar 

  320. Drews J (1986) Immunpharmakologie und Perspektiven. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  321. Droller MJ, Perlmann P, Schneider MU (1978) Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cells. Cell Immunol 39: 154

    PubMed  CAS  Google Scholar 

  322. Edwards BS, Hawkins MJ, Borden EC (1984) Comparative in vivo and in vitro activation of human natural killer cells by two recombinant α-interferons differing in antiviral activity. Cancer Res 44: 3135

    PubMed  CAS  Google Scholar 

  323. Ehrke MJ, Mihich E (1985) Effects of anticancer agents on immune responses. Trends Pharmacol Sci October: 412

    Google Scholar 

  324. Fleischmann WR Jr (1982) Potentiation of the direct anti cellular activity of mouse interferons: mutual synergism and interferon concentration dependence. Cancer Res 42: 869

    PubMed  CAS  Google Scholar 

  325. Gershon RK (1975) A disquisition on Suppressor T cells. Transplant Rev 26: 170

    PubMed  CAS  Google Scholar 

  326. Gewant WC, Chasin L, Tilson MD (1972) Lymph node-breast carcinoma interrelations in tissue culture. Surg Gynecol Obstet 133: 959

    Google Scholar 

  327. Goldie JH, Coldman AJ (1979) A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63: 1727

    PubMed  CAS  Google Scholar 

  328. Goodwin JS (1981) Prostaglandin E and cancer growth: potential for immunotherapy with prostaglandin synthetase inhibitors. In: Hersh EM et al. (eds), Augmenting agents in cancer therapy. Raven, New York, p 393

    Google Scholar 

  329. Hansen K, Mossman BT (1987) Generation of superoxide (O2) from alveolar macrophages exposed to asbestiform and nonfibrous particles. Cancer Res 47: 1681

    PubMed  CAS  Google Scholar 

  330. Heberman RB, Ortaldo JR, Bonnard GO (1979) Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature 227: 221

    Google Scholar 

  331. Heberman RB, Ortaldo JR, Mantovani A, Hobbs OS, Kung H-F, Pestka S (1982) Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes. Cell Immunol 67: 160

    Google Scholar 

  332. Heideman E, Reichmann K, Wilms K, Trenner J, Niethammer O (1982) Effect of human fibroblast interferon on natural killer cell activity: stimulation in vitro and inhibition in vivo. Klin Wochenschr 60: 625

    Google Scholar 

  333. Hellström KE, Hellström J (1974) Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol 18: 209

    PubMed  Google Scholar 

  334. Hercend T, Schmidt RE (1988) Characteristics and uses of natural killer cells. Immunol Today 9: 291

    PubMed  CAS  Google Scholar 

  335. Hersey P, Bindon C, Czerniecki M, Spurling A, Wass J, McCarthy WH (1983) Inhibition of interleukin 2 production by factors released from tumor cells. J Immunol 131: 2837

    PubMed  CAS  Google Scholar 

  336. Hickock OF (1972) The progressive lymph node defect in cancer patients. Surg Forum 21: 114

    Google Scholar 

  337. Höffken K, Meredith IB, Robins RA, Baldwin RW, Davies CJ, Blarney RW (1977) Circulating immune complexes in patients with breast cancer. Br Med J 2: 218

    PubMed  Google Scholar 

  338. Hoon DSB, Korn EL, Cochran AJ (1987) Variations in functional immunocompetence of individual tumor-draining lymph nodes in humans. Cancer Res 47: 1740

    PubMed  CAS  Google Scholar 

  339. Hoon DSB, Bowker RJ, Cochran AJ (1987) Suppressor cell activity in melanoma-draining lymph nodes. Cancer Res 47: 1529

    PubMed  CAS  Google Scholar 

  340. Kaye J, Janeway CA (1984) Induction of receptors for interleukin 2 requires T cell Ag: la receptor crosslin king and interleukin 1. Lymphokine Res 3: 175

    PubMed  CAS  Google Scholar 

  341. Kelley VE, Fiers W, Strom TB (1984) Cloned human interferon- γ, but not interferon-β or -α, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines. J Immunol 132: 240

    PubMed  CAS  Google Scholar 

  342. Keong A, Rabson AR (1983) Supernatant derived from a human hepatocellular carcinoma cell line (PLC/PRF/5) activates a population of T-suppressor cells. Cancer Immunol Immunother 15: 178

    PubMed  CAS  Google Scholar 

  343. Keong A, Herman J, Rabson AR (1983) Supernatant derived from a human hepatocellular carcinoma cell line (PLC/PRF/5) depresses natural killer (NK) cell activity. Cancer Immunol Immunother 15: 183

    PubMed  CAS  Google Scholar 

  344. Klein HO (1989) Untersuchungen zur Immuntherapie des metastasierenden Hypernephroms und anderer solider Tumoren. In: Kreidler I, Hündgen M (Hrsg) Aktuelle Immunologie 6, Regionale Tumortherapie mit Interferonen. Zuckschwerdt, München, S 13–29

    Google Scholar 

  345. Klein HO, Kreysch HG, Coerper C, Voigt P, Ruff I (1987) Preclinical and early clinical trial with mafosfamide as immune modulator. Methods Find Exp Clin Pharmacol 9: 627–640

    PubMed  CAS  Google Scholar 

  346. Kleinerman ES, Kurzrock R, Wyatt D, Quesada JR, Gutterman JU, Fidler IJ (1986) Activation or suppression of the tumoricidal properties of monocytes from cancer patients following treatment with human recombinant γ-Interferon. Cancer Res 46: 5401

    PubMed  CAS  Google Scholar 

  347. Koff WC, Fogler WE, Gutterman J, Fidler JJ (1985) Efficient activation of human blood monocytes to a tumoricidal state by liposomes containing human recombinant gamma interferon. Cancer Immunol Immunother 19: 85

    PubMed  CAS  Google Scholar 

  348. Lloyd RE, Blalock JE, Stanton GJ (1982) Cell-to-cell transfer of interferon-induced antiproliferative activity. Science 221: 953

    Google Scholar 

  349. Lotzova E (1985) Effector immune mechanisms in cancer. Nat Immun Cell Growth Regul 4: 293

    PubMed  CAS  Google Scholar 

  350. Lucero MA, Magdelenat H, Fridman WH, Pouillart P, Billardon C, Billiau A, Cantell K, Falcoff E (1982) Comparison of effects of leukocyte and fibroblast interferon on immunological parameters in cancer patients. Eur J Cancer Clin Oncol 18: 243

    PubMed  CAS  Google Scholar 

  351. Metcalf D (1985) Multi CSF-dependent colony formation by cells of a murine hemopoietic cell line: specificity and action ofmulti-CSF. Blood 65: 357

    PubMed  CAS  Google Scholar 

  352. Monson JRT, Ramsden C, Guillou PJ (1986) Decreased interleukin-2 production in patients with gastrointestinal cancer. Br J Surg 73: 483

    PubMed  CAS  Google Scholar 

  353. Morgan DA, Ruscetti FW, Gallo RC (1976) Selective in vitro growth of T-lymphocytes from normal human bone marrows. Science 193: 1007

    PubMed  CAS  Google Scholar 

  354. Nakamura M, Manser T, Pearson GDN, Daley MJ, Gefter ML (1984) Effect of IFN-γ on the immune response in vivo and on gene expression in vitro. Nature 307: 381

    PubMed  CAS  Google Scholar 

  355. Natali PG, Nicotra MR, Venturo I, Bigotti A, Giacomini P, Russo C (1988) Loss of expression of polymorphic determinants of HLA-A,B,C antigens in solid tumors. Abstracts of the Second International Conference of Anticancer Research, Saronis/Greece, Abstr N0417, p 1147

    Google Scholar 

  356. Nathan CF, Horowith CR, Harpe J de la, Vadhan-Raj S, Sherwins St, Oettgen HF, Krown SE (1985) Administration of recombinant interferon γ to cancer patients enhances monocyte secretion of hydrogen peroxide. Proc Natl Acad Sci USA 82: 8686

    PubMed  CAS  Google Scholar 

  357. Niemeyer U, Engel J, Scheffler G, Molge K, Sauerbier D, Weigert W (1984) Chemical characterization of ASTA Z 7557 (INN mafosfamide, CIS-4-sulfoethylthio-cyclophosphamide), a stable derivate of 4-hydroxy-cyclophosphamide. Invest New Drugs 2: 133

    PubMed  CAS  Google Scholar 

  358. Oettgen HF, Old U, Boyse EA (1971) Human tumor immunology. Med Clin North Am 55: 761

    PubMed  CAS  Google Scholar 

  359. Old L (1987) Polypeptide mediator network. Nature 326: 330

    PubMed  CAS  Google Scholar 

  360. Oleszak E, Stewart WE (1985) Potentiation of the antiviral and anticellular activities of interferons by mixtures of HuIFN-γ and HuIFN-α or HuIFN-β. J Interferon Res 5: 361

    PubMed  CAS  Google Scholar 

  361. Olsson L, Mathe G, Reizenstein P (1984) The biologic and immunologic response to tumors. In: Kuemmerle HP (ed) Clinical Chemotherapy, vol III: Antineoplastic chemotherapy. Thieme & Stratton, New York, p 308

    Google Scholar 

  362. Ortaldo JR, Timonen T, Mantovani A, Pestka S (1981) The effect of interferon on natural immunity. J Interferon Res 1: 241

    Google Scholar 

  363. Peri G, Polentarutti K, Sessa C, Mangioni C, Mantovani A (1981) Tumoricidal activity of macrophages isolated from human ascitic and solid ovarian carcinomas: augmentation by interferon, lymphokines and endotoxin. Int J Cancer 28: 143

    PubMed  CAS  Google Scholar 

  364. Pluznik DH, Cunningham RE, Noguchi PO (1984) Colony-stimulating factor (CSF) controls proliferation of CSF-dependent cells by acting during the Gl phase of the cell cycle. Proc Natl Acad Sci USA 81: 7451

    PubMed  CAS  Google Scholar 

  365. Rees RC, Buckle AM, Gelsthorpe K, James V, Potter CW, Rogers K, Jacob G (1988) Loss of polymorphic A and B locus HLA antigens in colon carcinoma. Br J Cancer 57: 374

    PubMed  CAS  Google Scholar 

  366. Rosenberg SA (1988) Immunotherapy of cancer using interleukin 2: current status and future prospects. Immunol Today 9: 58

    PubMed  CAS  Google Scholar 

  367. Rosenberg SA, Lotz MT, Muul LM et al. (1985) Observations in the systemic administration of autologous Iymphokine-activated killer cells and recombinant interleukin 2 to patients with metastatic cancer. N Engl J Med 313: 1485

    PubMed  CAS  Google Scholar 

  368. Roth JA, Grimm EA, Gupta RK, Ames RS (1982) Immunoregulatory factors derived from human tumors. I. Immunologic and biochemical characterization of factors that suppress lymphocyte proliferative and cytotoxic responses in vitro. J Immunol 128: 1955

    PubMed  CAS  Google Scholar 

  369. Ruggiero V, Tavernier J, Fiers W, Baglioni C (1986) Induction of the synthesis of tumor necrosis factor receptors by interferon-γ. Immunology 136: 2445

    CAS  Google Scholar 

  370. Saiki J, Dunegan MA, Fann AV, Koff EC (1986) Regulatory effects on macrophages of human recombinant interferons-α. J Interferon Res 6: 603

    PubMed  CAS  Google Scholar 

  371. Sakita M, Kageyama N, Majima S (1985) Comparative studies between liposomes containing muramyl dipeptide and various immunomodulators on activation of mouse peritoneal macrophages and NK cells. Oncology 42: 259

    PubMed  CAS  Google Scholar 

  372. Schiller JH, Groveman OS, Schmid SM, Willson JKV, Cummings KB, Borden EC (1986) Synergistic anti proliferative effects of human recombinant α 54- or β-interferon with γ-interferon on human cell lines of various histogenesis. Cancer Res 46: 483

    PubMed  CAS  Google Scholar 

  373. Schiller JH, Storer B, Willson JKV, Borden EC (1987) Phase I trial of combinations of recomb inant interferons and in patients with advanced malignancy. Cancer Treat Rep 71 : 945

    PubMed  CAS  Google Scholar 

  374. Schrier PI, van’t Veer L, Versteeg R, Peltenburg L, Ruiter OJ, Burgering B, Bos HL (1988) Activation of oncogenes in human melanoma: a message to the immune system? Abstracts of the Second International Conference of Anticancer Research, Abstr No 372, p 1131

    Google Scholar 

  375. Schwarz T (1988) Melanome hemmen Killerzellen durch eigene Zytokine. Vortrag auf dem Symposium „Immunodeficiency and Skin‟, Innsbruck

    Google Scholar 

  376. Sidman CL, Marshall JD, Shultz LD, Gray PW, Johnson HM (1984) γ-interferon is one of several direct B cell-maturing Iymphokines. Nature 309: 801

    PubMed  CAS  Google Scholar 

  377. Smith JJ, Mihich E, Ozer H (1987) In vitro effects of 4-hydroxyperoxy-cyclophosphamide on human immunoregulatory T subset function. Methods Find Exp Clin Pharmacol 9: 555

    PubMed  CAS  Google Scholar 

  378. Szuro-Sudol A, Nathan CF (1982) Suppression of macrophage oxidative metabolism by products of malignant and nonmalignant cells. J Exp Med 156: 945

    PubMed  CAS  Google Scholar 

  379. Thomas Y, Huchet R, Grandjon O (1981) Role of adherent suppressor cells in the depression of cell-mediated immunity in Hodgkin’s disease and lung carcinoma. Ann Inst Pasteur Immunol 132C: 167

    CAS  Google Scholar 

  380. Tilden AB, Balch CM (1982) A comparison of PGE2 effects on human suppressor cell function and on interleukin 2 function. J Immunol 129: 2469

    PubMed  CAS  Google Scholar 

  381. Tsujimoto M, Yip YK, Vilcek J (1986) Interferon-γ enhances expression of cellular receptors for tumor necrosis factor. J Immunol 136: 2441

    PubMed  CAS  Google Scholar 

  382. Vánky F, Stjernswärd J, Nilsonne U (1973) Differences in the tumor-associated reactivity of blood lymphocytes and tumor-draining lymph node cells in sarcoma patients. J NatI Cancer Inst 51: 17

    Google Scholar 

  383. Vose BM, Moore M (1985) Human tumor-infiltrating lymphocytes: a marker of host response. Semin Hematol 22: 27

    PubMed  CAS  Google Scholar 

  384. Wasielewski E von, Sedlacek HH (1986) Alte und neue Probleme der Tumorforschung. Dtsch Med Wochenschr 111 : 630

    Google Scholar 

  385. Weigent DA, Langford MP, Fleischmann WR Jr, Stanton GJ (1983) Potentiation of lymphocyte natural killing by mixtures of alpha or beta interferon with recombinant gamma interferon. Infect Immun 40: 35

    PubMed  CAS  Google Scholar 

  386. Werkmeister J, McCarthy W, Hersey P (1981) Suppressor cell activity in melanoma patients. I. Relation to tumor growth and immunoglobulin levels in vivo. Int J Cancer 28: 1

    PubMed  CAS  Google Scholar 

  387. Yip YK, Barrowclough BS, Urban C, Vi1cek J (1982) Molecular weight of human gamma interferon is similar to that of other human gamma interferons. Science 215: 411

    PubMed  CAS  Google Scholar 

  388. Yu A, Watts H, Jaffe N, Parkman R (1977) Concomitant presence of tumor-specific cytotoxic and inhibitor lymphocytes in patients with osteogenic sarcoma. New Engl J Med 297: 121

    PubMed  CAS  Google Scholar 

  389. Zembala M, Mytar B, Popiela T, Asherson GL (1977) Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells. Int J Cancer 19: 605

    PubMed  CAS  Google Scholar 

  390. Ardenne M von (1987) Sauerstoff-Mehrschritt-Therapie, 4. Aufl. Thieme, Stuttgart

    Google Scholar 

  391. Berger M, Schmähl D (1983) Studies on the tumor-inhibiting effects of Iscador in experimental animal tumors. J Cancer Res Clin Oncol 105: 262–265

    PubMed  CAS  Google Scholar 

  392. Blumenschein W (1986) Biologische Heilweisen bei Krebs. Ennsthaler, Steyr

    Google Scholar 

  393. Bohn B, Nebe CT, Birr C (1987) Durchflußzytometrische Untersuchungen auf immunmodulatische Wirkungen von Eleutherococcus S.-Extrakt. Arzneimittelforschung 37: 1193–1196

    PubMed  CAS  Google Scholar 

  394. Braun H, Frohne D (1987) Heilpflanzenlexikon fUr Arzte und Apotheker, 5. Aufl. Fischer, Stuttgart New York

    Google Scholar 

  395. Bruntsch U (1982) Entwicklung und Erprobung neuer Medikamente in der Onkologie. MMW 124: 356

    CAS  Google Scholar 

  396. Curtze A (o Jg) Ein Pflanzenextrakt im Einsatz gegen Krebs (Firmenbroschüre Neu-Isenburg)

    Google Scholar 

  397. Diet, Nutrition and Cancer (1982) National Academy Press, Washington DC [deutsch: Ernährung und Krebs (1984) BMFT Bonn]

    Google Scholar 

  398. Dold U (1986) Neue und alternative Therapieformen des Bronchialkarzinoms. 32. Kongrs. Dtsch Ges Pneumol Tuberkulose

    Google Scholar 

  399. Fasching (1988) Teepilz Kombucha, 9. erw Aufl. Ennsthaler, Steyr

    Google Scholar 

  400. Gutsch J (1988) Prospektive Studie beim radikal operierten Mamma-Karzinom mit Polychemotherapie, Helixor und unbehandelter Kontrolle. Dtsch Onkol 20: 94

    Google Scholar 

  401. Hauser SP (1987) Krebspatient und Paramedizin. Praxis 76: 1151–1178 (Sondernummer 42)

    Google Scholar 

  402. Hornung J (1989) Methodisches zu den klinischen Studien zur Misteltherapie des Krebses. Therapeutikon 3: 16–21

    Google Scholar 

  403. Jäger G (1988) Leben mit Krebs. Mosaik, München

    Google Scholar 

  404. Jungi WF (1985) Moglichkeiten und Grenzen alternativer Krebstherapie. Kassenarzt 31: 17

    Google Scholar 

  405. Jungi WF (1986) Risiken alternativer Krebsbehandlung. Onkologie 9: 231

    PubMed  CAS  Google Scholar 

  406. Jungi WF (1988) Alternativen zur Schulmedizin in der Krebstherapie. Krankenhausarzt 61: 145–150

    Google Scholar 

  407. Jungi WF (1988) Diätetik bei Krebserkrankungen. Internist 29: 492–498

    PubMed  CAS  Google Scholar 

  408. Jungi WF, Senn HJ (Hrsg) (1986) Krebs und Alternativmedizin. Zuckschwerdt, München Bern Wien San Francisco

    Google Scholar 

  409. Kjaer M (1988) Misteltenbehandling af metastaserende nyrecancer. Ugeskr Laeger 150: 1923

    PubMed  CAS  Google Scholar 

  410. Leroi R (1987) Misteltherapie. Freies Geistesleben, Stuttgart

    Google Scholar 

  411. Luther P, Becker H (1987) Die Mistel. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  412. Nagel GA, Schmahl D, Hossfeld DK (1989) Krebsmedikamente mit fraglicher Wirksamkeit, 4. Aufl. Aktuelle Onkologie 49, Zuckschwerdt, München Bern Wien San Francisco

    Google Scholar 

  413. Oepen I (Hrsg) (1985) An den Grenzen der Schulmedizin. Deutscher Ärzteverlag, Köln

    Google Scholar 

  414. Renner H (1979) Klinische Aspekte einer Tumorimmuntherapie mit lyophilisierten fetalen Zellen. Cytobiol Rev 3: 3–6

    Google Scholar 

  415. Renner H et al. (1980) Erfahrungen mit Resistocell als Zusatztherapie beim metastasierenden Mammacarcinom. Cytobiol Rev 4: 109–114

    Google Scholar 

  416. Salzer G (1988) Prospektiv randomisierte Studie: Operiertes Magenkarzinom. Dtsch Z Onkol 20: 90–93

    Google Scholar 

  417. Salzer G, Havelec L (1983) Adjuvante Iscadorbehandlung nach operiertem Magenkarzinom. Krebsgeschehen 15: 106

    Google Scholar 

  418. Schmähl D, Berger M (1983) Gedanken zur sogenannten unkonventionellen Krebsbehandlung. Med Welt 34: 3

    Google Scholar 

  419. Schmähl D, Einem J von (1956) Experimentelle Prüfung von „Krebsmitteln‟. Dtsch Med Wochenschr 81: 293

    PubMed  Google Scholar 

  420. Schnizer W et al. (1985) Untersuchungen zur Krebs-Mehrschritt-Therapie nach von Ardenne. Dtsch Ärztebl 82: 2026–2028

    Google Scholar 

  421. Schreml W (1984) Zytoplasmatische Therapie. MMW 126: 234–238

    CAS  Google Scholar 

  422. Schumacher K (1986) Die Problematik der sogenannten unkonventionellen Krebstherapie. Med Klin 81: 423

    CAS  Google Scholar 

  423. Schweiz Krebsliga/Schweiz Ges Onkol (1989) Dokumentationen der Studiengruppe mit unbewiesener Wirkung in der Onkologie, Nr.I-22 (Sammelseparatum aus Schweiz Rundsch Med Prax)

    Google Scholar 

  424. Theurer KE (Hrsg) (1985) Neue Perspektiven in der Onkologie. Therapiewoche 35: 77–130

    Google Scholar 

  425. Wobe-Mugos (1987) Broschüre. Fa. Mucos, Geretsried/Wien

    Google Scholar 

  426. Anemueller H (1980) Das Grunddiät-System. Leitfaden der Emährungstherapie. Hippokrates, Stuttgart

    Google Scholar 

  427. Armstrong BK, McMichael AJ, MacLennan R (1982) Diet. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention. Saunders, Philadelphia

    Google Scholar 

  428. Brenner U (1987) Emahrungsstörungen durch chirurgische Eingriffe. In: Sauer R, Thiel H-J (Hrsg) Emährungsprobleme in der Onkologie. Zuckschwerdt, München

    Google Scholar 

  429. Canzler H (1983) Die Emährung des Krebskranken. In: Schlierf G (Hrsg) Emährung und Krebs. Wissenschaftliche Verlagsgesellschaft, Stuttgart

    Google Scholar 

  430. Committee on Diet, Nutrition, and Cancer - National Research Council (1982) Diet, nutrition, and cancer. National Academy Press, Washington DC. [Deutsche Übersetzung der Zusammenfassung: Ernährung und Krebs (1984) Bundesministerium f. Forschung u. Technologie, Bonn]

    Google Scholar 

  431. Douwes FR (1984) Ernährungstherapie bei Krebskranken. Ärztez Naturheilverf 25: 5

    Google Scholar 

  432. Jungi WF (1982) Was von „Krebsdiaten‟ zu halten ist. MMW 124: 26

    CAS  Google Scholar 

  433. Koerber KW von, Männie T, Leitzmann C (1982) Vollwert-Ernährung, 2.Aufl Haug, Heidelberg

    Google Scholar 

  434. Kollath W (1951) Die Ordnung unserer Nahrung, 2. Aufl. Hippokrates, Stuttgart

    Google Scholar 

  435. Lützner H (1983) Aktive Diätetik bei chronischen Leberkrankheiten. Ärztez Naturheilverf 24: 518

    Google Scholar 

  436. Müller JM, Brenner U, Schindler J (1982) Das Kurzdarrn-Syndrom. Leber Magen Darrn 12: 60

    Google Scholar 

  437. Ollenschläger G, Jansen S, Fischer H, Mödder B (1987) Zur Pathogenese und klinischen Bedeutung der Anorexie onkologischer Patienten. In: Sauer R, Thiel H-J (Hrsg) Ernährungsprobleme in der Onkologie. Zuckschwerdt, München

    Google Scholar 

  438. Pischinger A (1980) Das System der Grundregulation, 3. Aufl. Haug, Heidelberg

    Google Scholar 

  439. Rauch E (1988) Blut- und Säfte-Reinigung, 18.Aufl. Haug, Heidelberg

    Google Scholar 

  440. Strohmeyer G (1988) Diätetik und künstliche Ernährung. In: Riecker G (Hrsg) Therapie innerer Krankheiten, 6. Aufl. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  441. Theologides A (1979) Cancer cachexia. Cancer 43: 2004

    PubMed  CAS  Google Scholar 

  442. Thiel H-J (1987) Ernahrungsstorungen durch Strahlentherapie. Ursachen-Prophylaxe-Therapie. In: Sauer R, Thiel H-J (Hrsg) Ernährungspröbleme in der Onkologie. Zuckschwerdt, München

    Google Scholar 

  443. Thielemann-Jonen I (1982) Probleme nach chirurgischen Eingriffen am Dickdarrn. Leber Magen Darrn 12: 64

    CAS  Google Scholar 

  444. Zabel W (1980) Die interne Krebstherapie und die Ernährung des Krebskranken, 8.Aufl. Bircher-Benner, Bad Homburg v. d. H. Zürich

    Google Scholar 

  445. Bothe A jr, Valerio D, Bistrian BR, Blackburn GL (1979) Randomized control trial of hospital nutritional support during abdominal radiotherapy. J Parenter Enter Nutr 3: 292

    Google Scholar 

  446. Brennan MF (1981) Total parenteral nutrition of the cancer patient. N EnglJ Med 305: 375

    CAS  Google Scholar 

  447. Broviac JW, Cole JJ, Scribner BH (1973) A silicone rubber atrial catheter for prolonged parenteral nutrition. Surg Gynecol Obstet 136: 602

    PubMed  CAS  Google Scholar 

  448. Flemming CR, Witzke DJ, Beart R W (1980) Catheter-related complications in patients receiving home parenteral nutrition. Ann Surg 192: 593

    Google Scholar 

  449. Food and Nutrition Board (1973) Recommended dietary allowances, 8th rev edn. National Academy of Science, Washington D. C.

    Google Scholar 

  450. Issell BF, Valdivieso M, Zaren HA (1978) Protection against chemotherapy toxicity by IV hyperalimentation. Cancer Treat Rep 62: 1139

    PubMed  CAS  Google Scholar 

  451. Miller DG, Ivey M, Ivey T, Scribner BH (1980) Experience with an indwelling right atrial catheter for home parenteral nutrition. Surg Gynecol Obstet 151: 108

    PubMed  CAS  Google Scholar 

  452. Müller JM (1982) Die parenterale Ernährung zu Hause. Travenol, München (Ein Handbuch für Patienten)

    Google Scholar 

  453. Müller JM, Keller HW, Brenner U, Walter M (1984) Stoffwechselkonsequenzen der parenteralen Ernährung bei Tumorpatienten. Leber Magen Darm 14: 68

    PubMed  Google Scholar 

  454. Müller JW, Keller HW, Brenner U, Walter M (1984) Die ambulante parenterale Dauerernahrung bei Kranken mit Kurzdarmsyndrom. Internist 25: 292

    PubMed  Google Scholar 

  455. Nixon D, Rudman D, Heymsfield S (1979) Abnormal hyperalimentation response in cachectic cancer patients. Proc Am Assoc Cancer Res Am Soc Clin Oncol 20: 173

    Google Scholar 

  456. Shamberger RC, Brennan MF, Goodgame JT (1981) Effect of total parenteral nutrition (TPN) on metabolic parameters of patients undergoing ablative chemotherapy. Proc Am Assoc Cancer Res Am Soc Clin Oncol 22: 420

    Google Scholar 

  457. Steiger E, Grundfest S (1979) Experience with the BROVIAC-catheter for prolonged parenteral alimentation. J Parenter Enter Nutr 3: 45

    Google Scholar 

  458. Strobel CT, Byrne WJ, Ament ME (1979) Home parenteral nutrition in children with Crohn’s disease. An effective management alternative. Gastroenterology 77: 272

    PubMed  CAS  Google Scholar 

  459. Valerio D, Overett L, Malcolm A, Blackburn GL (1978) Nutritional support for cancer patients receiving abdominal and pelvic radiotherapy: a randomized prospective clinical experiment of intravenous versus oral feeding. Surg Forum 29: 145

    PubMed  CAS  Google Scholar 

  460. Baines M (1983) The principles of symptom control. In: Saunders C, Summers DH, Teller N (eds) Hospice: the living idea, 2nd edn. Arnold, London

    Google Scholar 

  461. Baines M (1984) Control of other symptoms. In: Saunders C (ed) The management of terminal malignant disease, 2nd edn. Arnold, London

    Google Scholar 

  462. Regnard CFB, Davies A (1986) A guide to symptom relief in advanced cancer, 2nd edn Haigh & Hochland, Manchester

    Google Scholar 

  463. Saunders C, Baines M (1984) Living with dying. The management of terminal disease, 3rd edn. Oxford University Press, Oxford

    Google Scholar 

  464. Stott NCH, Finlay IG (1986) Care of the dying, 2nd edn. Churchill Livingstone, Edinburgh

    Google Scholar 

  465. Twycross RG, Lack SA(1984) Symptom control in far advanced cancer: Pain relief, 2nd edn. Pitman, London

    Google Scholar 

  466. Twycross RG, Lack SA (1986) Control of alimentary symptoms in far advanced cancer. Churchill Livingstone, Edinburgh

    Google Scholar 

  467. Twycross RG, Lack SA (1986) Therapeutics in terminal cancer, 2nd edn. Churchill Livingstone, Edinburgh

    Google Scholar 

  468. Twycross RG, Lack SA (1989) Therapie bei Krebs im Endstadium. Fischer, Stuttgart New York (Übersetzung und Bearbeitung von Göpfert C)

    Google Scholar 

  469. Aaronson NK, Beckmann I (1987) Quality of life of cancer patients. Raven, New York

    Google Scholar 

  470. Aaronson NK, Bullinger M, Ahmedzai S (1988) A modular approach to quality of life. In: Scheurlen H (ed) Recent results in cancer research: Cancer clinical trials. Heidelberger Symposium 3.87, Freiburg (Breisgau), Vol 111. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  471. Ackenheil M (1985) Spektrum Psychopharmaka. Aesopus, Zug (Arzneimitteltherapie heute, Band 36)

    Google Scholar 

  472. Adami S, Salvagno G, Guarrera G et al. (1985) Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton. J Uroll 34: 1152–1154

    Google Scholar 

  473. Adler RH, Hürny C (1988) Differential diagnosis of pain in cancer patients. Rec Res Cancer Res 108: 1–8

    CAS  Google Scholar 

  474. Ahles TA, Blanchard EB, Ruckdeschel JC (1983) The multi-dimensional nature of cancer-related pain. Pain 17: 277–288

    PubMed  CAS  Google Scholar 

  475. Ahuja BR (1983) Analgesic effect of intrathecal ketamine in rats. Br J Anaesth 55: 991–995

    PubMed  CAS  Google Scholar 

  476. Aly A (1987) Prostaglandins in clinical treatment of gastroduodenal mucosal lesions : A review. Scand J Gastroenterol [Suppl] 22/134: 43–49

    Google Scholar 

  477. Ameer B, Greenblatt OJ (1977) Acetaminophen. Ann Intern Med 87: 202

    PubMed  CAS  Google Scholar 

  478. American Pain Society (1987) Principles of analgesic use in the treatment of acute pain or chronic cancer pain. Clin Pharmacology 6: 523–532

    Google Scholar 

  479. Armstrong PJ, Bersten A (1986) Normeperidine toxicity. Anesth Analg 65: 536–538

    PubMed  CAS  Google Scholar 

  480. Arnér S, Arnér B (1984) Effects of epidural morphine on different types of pain associated with cancer. Pain [Suppl] 2: S 18

    Google Scholar 

  481. Baines MJ (1984) Cancer pain. Postgrad Med J 60: 852–857

    PubMed  CAS  Google Scholar 

  482. Baines MJ (1988) Nausea and vomiting in the patients with advanced cancer. J Pain Sympt Manag 312: 81–85

    Google Scholar 

  483. Barkas G, Duafala ME (1988) Advances in cancer pain management: A review of patient-controlled analgesia. J Pain Sympt Manag 3: 150–160

    CAS  Google Scholar 

  484. Beaver WT, Wallenstein SL, Houde RW, Rogers A (1966) A comparison of the analgesic effects of methotrimeprazine and morphine in patients with cancer. Clin Pharmacol Ther 5: 436–446

    Google Scholar 

  485. Bennett RL (1985) Patient-controlled analgesia for the treatment of the pain of terminal cancer. In: Harmer M, Rosen M, Vickers MD (eds) Patient-controlled analgesia. Blackwell, Oxford

    Google Scholar 

  486. Bernatzky G, Jurna I (1986) Intrathecal injection of codein, buprenorphine, tilidine, tramadol, nefopam depresses the tail-flick responds in rats. Eur J Pharmacol 120: 75–80

    PubMed  CAS  Google Scholar 

  487. Bischko J (1978) Verwendung des Laserstrahls in der Akupunktur. MMW 120 (2–3): 67–68

    CAS  Google Scholar 

  488. Blanchard J, Menk EJ, Ramamurthy S, Hoffman J (1988) Subarachnoid and epidural calcitonin for the management of cancer pain. Anesth Analg 67 :S17

    Google Scholar 

  489. Bonica JJ (1978) Cancer pain: a major national health problem. Cancer Nurs 1: 313–316

    PubMed  CAS  Google Scholar 

  490. Bonica JJ (1985) Control of bone cancer pain. In: Garattini S (ed) Bone resorption, metastasis, and diphosphonates. Raven, New York, pp 137–180

    Google Scholar 

  491. Bonica JJ, Halpern LM (1972) Analgesics. In: Drugs of choice 1972–73. Mosby, St. Louis, pp 185–217

    Google Scholar 

  492. Boreus LO, Sandberg F (1959) The influence of three phenothiazine derivates and of amiphenazole on the action of methadone. J Pharmacol 11: 449–455

    CAS  Google Scholar 

  493. Bowdler I (1989) Die rückenmarknahe Applikation von analgetisch wirkenden Substanzen. In: Hankemeier U, Bowdler I, Zech D (Hrsg) Tumorschmerztherapie. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  494. Breukelen FJM, van Bijvoet OLM, Osterom AT (1979) Inhibition of osteolytic bone lesions by (3-amino-1-hydroxy-propylidene)-1,1 biphosphonate (ADP). Lancet 14: 803–805

    Google Scholar 

  495. Brigden ML, Barnett JM (1987) A practical approach to improving pain control in cancer patients. West J Med 146: 580–584

    PubMed  CAS  Google Scholar 

  496. Bromm B, Meier W, Scharein E (1983) Antagonism between tilidine and naloxone on cerebral potentials and pain rating in man. Eur J Clin Pharmacol 87: 431–439

    CAS  Google Scholar 

  497. Bromm B, Herrmann MW, Scharein E (1988) Zur analgetischen Wirksamkeit von Paracetamol und Acetylsalicylsiiure im experimentellen Schmerzmodell. Schmerz Pain Douleur 9: 5–11

    Google Scholar 

  498. Bruera E, Roca E, Cedaro L et al. (1985) Action of oral methylprednisolone in terminal cancer patients: A prospective randomized double-blind study. Cancer Treat Rep 69: 751–754

    PubMed  CAS  Google Scholar 

  499. Bruera E, Brennels C, Michaud M et al. (1987) Continuous sc infusion of narcotics using a portable disposable device in patients with advanced cancer. Cancer Treat Rep 71/6: 635–637

    PubMed  CAS  Google Scholar 

  500. Brune K (1984) Peripher wirkende Analgetika. In: Zimmermann M, Handwerker O (Hrsg) Schmerz - Konzepte und ärztliches Handeln. Springer, Berlin Heidelberg New York Tokyo, S44–60

    Google Scholar 

  501. Brune K (1986) Comparative pharmacology of „non-opioid‟ analgesics. Med Toxicol 1 [Suppl 1]: 1–9

    PubMed  CAS  Google Scholar 

  502. Brune K (1986) Pharmakologie der peripher wirkenden Analgetika. In: Mihatsch MJ (Hrsg) Das Analgetikasyndrom. Thieme, Stuttgart, S 3–18

    Google Scholar 

  503. Brune K (1986) Schmerzmittel auf dem Prüfstand. Fortschr Med 104/25: 483–488

    PubMed  CAS  Google Scholar 

  504. Brune K, Lanz R (1984) Mode of action of peripheral analgesics. Arzneimittelforschung 34 (II)/9a: 1060–1065

    PubMed  CAS  Google Scholar 

  505. Brune K, Dietzel K, Möller N (1986) Pharmakologie des Schmerzes. In: Wörz R (Hrsg) Pharmakotherapie bei Schmerz. VHC, Weinheim, S 45–93

    Google Scholar 

  506. Buy IN, Moss AA., Singler RC (1982) CT guided celiac plexus and splanchnic nerve neurolysis. J Comput Assist Tomogr 6/2: 315–319

    PubMed  CAS  Google Scholar 

  507. Campbell CF, Mason JB, Weiler JM (1983) Continuous subcutaneous infusion of morphine for the pain of terminal malignancy. Ann Intern Med 98/1: 51–52

    PubMed  CAS  Google Scholar 

  508. Carlsson KH, Helmreich J, Jurna I (1986) Activation of inhibition from the periaqueductal grey matter mediates central analgesic effect of metamizol (dipyrone). Pain 27: 373–390

    PubMed  CAS  Google Scholar 

  509. Carlsson KH, Helmreich J, Jurna I (1986) Comparison of central antinociceptive and analgesic effects of the pyrazolone derivates, metamizol (Dipyrone) and aminophenazone („Pyramidon‟). Schmerz Pain Douleur 3: 93–100

    Google Scholar 

  510. Casey KL (1982) Neural mechanisms of pain: An overview. Acta Anaesthesiol Scand [Suppl] 74: 13

    CAS  Google Scholar 

  511. Cavenar JO, Maltebie AA (1976) Another indication for haloperidol. Psychosomatics 17: 128–130

    PubMed  Google Scholar 

  512. Challenger JH (1978) Sympathetic nervous system blocking and pain relief. In: Swerdlow M (ed) Relief of intractable pain, 2nd edn. Elsevier, Amsterdam, pp 157–182

    Google Scholar 

  513. Chatterton P (1988) Physiotherapy for the terminally ill. Physiotherapy 74/1: 42–46

    Google Scholar 

  514. Chrubasik J, Falke KJ, Blond S, Meynadier J (1987) Epidural salmon calcitonin-infusion in treatment of cancer pain. Schmerz Pain Douleur 1: 23–27

    Google Scholar 

  515. Cleeland CS (1987) Nonpharmacological management of cancer pain. J Pain Sympt Manag 2/2: S23–S28

    CAS  Google Scholar 

  516. Cooper SA (1981) Comparative efficacies of aspirin and acetaminophen. Arch Intern Med 141: 23

    Google Scholar 

  517. Copping J, Willix R, Kraft R, Arbor A (1969) Palliative chemical splanchnicectomy. Arch Surg 98: 418–420

    PubMed  CAS  Google Scholar 

  518. Cordes M, Panitz N, Utech C (1987) Schmerztherapie bei Knochenmetastasen. Dtsch Med Wochenschr 112/10: 405

    PubMed  CAS  Google Scholar 

  519. Cowie RA, Hitchcock ER (1982) The late results of anterolateral cordotomy for pain relief. Acta Neurochir 64: 39–50

    CAS  Google Scholar 

  520. Coyle N, Mauskop A, Maggard J, Foley K (1986) Continuous subcutaneous infusions of opiates in cancer patients with pain. Oncol Nurs Forum 13/4: 53–57

    PubMed  CAS  Google Scholar 

  521. Daftary SN, Mehta AC, Nunavati N (1980) A controlled comparison of dipyrone and paracetamol in postoperative pain. Curr Med Res Opin 6: 614

    PubMed  CAS  Google Scholar 

  522. Dammann HG, Dau B, Dreyer M, Walter THA, Müller P, Simon B (1987) Endoskopische Untersuchungen zur Magenverträglichkeit von Acetylsalicylsäure (ASS) und anderen nichtsteroidalen Antirheumatika beim Menschen - ein Überblick. In: Simon B (Hrsg) Nichtsteroidale Antirheumatika und Gastrointestinaltrakt. Schattauer, Stuttgart, S 49–69

    Google Scholar 

  523. Daut RL, Cleeland CS (1982) The prevalence and severity of pain in cancer. Cancer 50: 1914–1918

    Google Scholar 

  524. Desmeules J, Dayer P (1988) Why is codeine unreliable for cancer pain control? J Pain Sympt Manag 3/3: S20

    Google Scholar 

  525. Devor M, Govrin-Lippmann R, Raber P (1985) Corticosteroids suppress ectopic neural discharge originating in experimental neuromas. Pain 22: 127–137

    PubMed  CAS  Google Scholar 

  526. Dickson RJ, Russell PSB (1982) Continuous subcutaneous analgesics for terminal care at home. Lancet I: 165

    Google Scholar 

  527. Dickson RJ, Howard B, Campbell J (1984) The relief of pain by subcutaneous infusion of diamorphine. In: Wilkes E (ed) Advances in morphine therapy. Royal Society of Medicine International Congress and Symposiums Series, No. 64, London

    Google Scholar 

  528. Dorn M (1987) Ibuprofen in der klinischen Praxis. Rheuma + Schmerz u. Entzündung 7/1: 29–36

    Google Scholar 

  529. Droste C (1986) Medikamentöse Schmerztherapie in der Inneren Medizin. In: Wörz R (Hrsg) Pharmakotherapie bei Schmerz. VHC, Weinheim, S 95–190

    Google Scholar 

  530. Elliott F, Little A, Milbrandt W (1976) Carbamazepin for phantom-limb phenomena. N Engl J Med 295: 678

    PubMed  CAS  Google Scholar 

  531. Elomaa I, Blomqvist C, Gröhn P et al. (1983) Long term controlled trial with diphosphonate in patients with osteolytic bone metastases. Lancet I: 146–149

    Google Scholar 

  532. Ettinger AB, Portenoy RK (1988) The use of Corticosteroids in the treatment of symptoms associated with cancer. J Pain Sympt Manag 3/2: 99–103

    CAS  Google Scholar 

  533. Fahrliinder H (1986) Analgetika und Magen. In: Mihatsch MJ (Hrsg) Das Analgetikasyndrom. Thieme, Stuttgart, S 42–46

    Google Scholar 

  534. Farcot JM, Laugner B, Muller A, et al. (1983) Subdural-arachnoid neurolytic block in cervical pain. Pain 17: 316–317

    PubMed  CAS  Google Scholar 

  535. Filshie J, Redman D (1985) Acupuncture and malignant pain problems. Eur J Clin Oncol 11: 389–394

    CAS  Google Scholar 

  536. Filshie J, Golding S, Robbie DS, Husband JE (1983) Unilateral computerized tomography guided coeliac plexus block: a technique for pain relief. Anaesthesia 38: 498–503

    PubMed  CAS  Google Scholar 

  537. Fiore CE, Castorina F, Malatino LS, Tamburino C (1983) Analgesic activity of calcitonin: Effectiveness of the epidural and subarachnoidal routes in man. Int J Clin Pharmacol Res 3: 257

    PubMed  CAS  Google Scholar 

  538. Fischer MV, Eibach J, Schmidt M (1986) Schmerztherapie beim Tumorpatienten. Anaesth Intensivther Notfallmed 21: 78–81

    CAS  Google Scholar 

  539. Flanigan DP, Kraft RO (1978) Continuing experience with palliative chemical splanchnicectomy. Arch Surg 113: 509–511

    PubMed  CAS  Google Scholar 

  540. Flower FJ, Vane JR (1972) Inhibition of prostaglandin synthetase in brain explains the antipyretic activity of paracetamol (4-Acetaminophenol). Nature 240: 410

    PubMed  CAS  Google Scholar 

  541. Foley KM (1979) Pain syndromes in patients with cancer. In: Bonica JJ, Ventafridda V (eds) Advances in pain research and therapy, vol 2. Raven, New York, pp 59–75

    Google Scholar 

  542. Foley KM (1985) The treatment of cancer pain. N Engl J Med 313: 84–95

    PubMed  CAS  Google Scholar 

  543. Foley KM (1987) Cancer pain syndromes. J Pain Sympt Manag 2: 13–17

    Google Scholar 

  544. Foley KM, Sundaresan N (1985) Management of cancer pain. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer - Principles and practice of oncology. Lippincott, Philadelphia, pp 1940–1961

    Google Scholar 

  545. Forth W (1985) Spasmolytische Effekte von Pyrazolonen. In: Brune K, Lanz R (Hrsg) 100 Jahre Pyrazolone. Urban & Schwarzenberg, München, S 139–143

    Google Scholar 

  546. Fox EJ, Melzack R (1976) Transcutaneous electrical stimulation and acupuncture: Comparison of treatment for low-back pain. Pain 2: 141–148

    PubMed  CAS  Google Scholar 

  547. Friedberg KD, Rüfer R (1987) Opiate und opiatähnliche Verbindungen. Fischer, Stuttgart

    Google Scholar 

  548. Frölich JC (1985) Wirkung von Metamizol auf die Prostaglandinsynthese des Menschen. In: Brune K, Lanz R (Hrsg) 100 Jahre Pyrazolone. Urban & Schwarzenberg, München, S 127–143

    Google Scholar 

  549. Gabka J (1978) Die analgetische Potenz von Valoron N. Bestimmungen der Dosisrelationen durch Reizschwellenmessungen. Krankenhausarzt 51: 431–439

    Google Scholar 

  550. Gerbershagen HU (1981) Neurolysis. Subarachnoid neurolytic blockade. Acta Anaesthesiol Belg 32: 45–57

    PubMed  CAS  Google Scholar 

  551. Getto CJ, Sorkness CA, Howell T (1987) Antidepressants in chronic pain. J Pain Sympt Manag 2: 9–18

    CAS  Google Scholar 

  552. Glynn C, Dawson D, Sanders R (1988) A double-blind comparison between epidural morphine and epidural c10nidine in patients with chronic non-cancer pain. Pain 34: 123–128

    PubMed  CAS  Google Scholar 

  553. Gourlay GK, Cherry DA, Cousins MJ (1986) A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain 25: 297–312

    PubMed  CAS  Google Scholar 

  554. Greenberg HS, Kim J, Posner JB (1980) Epidural spinal cord compression from metastatic tumor: Results with a new treatment protocol. Ann Neurol 8: 361–366

    PubMed  CAS  Google Scholar 

  555. Greenwald HP, Bonica JJ, Bergner M (1987) The prevalence of pain in four cancers. Cancer 60: 2563–2569

    PubMed  CAS  Google Scholar 

  556. Greiner L (1985) Punktionssonographische Alkoholneurolyse der Coeliakalganglien. Dtsch Med Wochenschr 110: 833–836

    PubMed  CAS  Google Scholar 

  557. Groh R, Schindera A, Werringloer M (1971) Klinische Erfahrungen mit dem neuen Analgetikum Tilidin-HCL. Med Klin 66: 1241–1245

    PubMed  CAS  Google Scholar 

  558. Grond S, Zech D, Horrichs-Haermeyer G, Lehmann KA (1989) Schmerztherapie bei sterbenden Tumorpatienten. Anaesthesist [Suppl 1] 38: 107

    Google Scholar 

  559. Grond S, Zech D, Schug SA, Meuser T, Stobbe B, Lehmann KA (1989) Schmerzdiagnose und Schmerztherapie bei malignen urologischen Erkrankungen. Akt Uro1 20: 300–306

    Google Scholar 

  560. Gundert-Remy U (1987) Unerwünschte Wirkungen von Schmerz- und Rheumamitteln. In: Friedberg KD, Rüfer R (Hrsg) Antiphlogistisch und antipyretisch wirkende Analgetika - 2. Mannheimer Therapiegespräch. Fischer, Stuttgart, S 17–26

    Google Scholar 

  561. Haglund U (1987) Role of histamine H2 receptor antagonists in non-operative management of gastroduodenal ulcer haemorrhage. Scand J Gastroenterology [Suppl] 22/134: 39–42

    Google Scholar 

  562. Hankemeier U (1989) Chemische Neurolysen. In: Hankemeier U, Bowdler I, Zech D (Hrsg) Tumorschmerztherapie. Springer, Berlin Heidelberg New York Tokyo, S 62–75

    Google Scholar 

  563. Hankemeier U, Bowdler I, Zech D et al. (1989) Kasuistik. In: Hankemeier U, Bowdler I, Zech D (Hrsg) Tumorschmerztherapie. Springer, Berlin Heidelberg New York Tokyo S.150–156

    Google Scholar 

  564. Hanks GW (1984) Psychotropic drugs. Postgrad Med J 60: 881–885

    PubMed  CAS  Google Scholar 

  565. Hanks GW, Trueman T, Twycross RG (1983) Corticosteroids in terminal cancer. A prospective analysis of current practice. Postgrad Med J 59: 702–706

    PubMed  CAS  Google Scholar 

  566. Hanning CD, Smith G (1988) The morphine hydrogel suppository: a new sustained release rectal preparation. J Pain Sympt Manag 3/3: S19

    Google Scholar 

  567. Hays H (1988) The use of hyaluronidase to promote absorption of fluid and pharmacological agents from the subcutaneous space. J Pain Sympt Manag [Suppl] 3/3: 15

    Google Scholar 

  568. Heel RC, Brodgen TM, Speight TM, Avery GS (1979) Buprenorphine: a review of its pharmacological properties and therapeutic efficiency. Drugs 17: 81–110

    PubMed  CAS  Google Scholar 

  569. Hennies HH, Friderichs E, Schneider J (1988) Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittelforschung 38: 877- 880

    PubMed  CAS  Google Scholar 

  570. Hilgard ER (1975) The alleviation of pain by hypnosis. Pain 1: 213–231

    PubMed  CAS  Google Scholar 

  571. Houde RW (1966) On assaying analgesics in man. In: Knighton RS, Dumke PR (eds) Pain. Little, Brown, Boston

    Google Scholar 

  572. Hougs W, Skouby AP (1957) The analgesic actions of analgesics, antihistamines and chlorpromazine in volunteers. Acta Pharmacol Toxicol 13: 405–409

    CAS  Google Scholar 

  573. Huber HP (1978) Psychologische Wirkungspriifung eines neuen Analgetikums aus der Cyclohexanol-Reihe. Ein Beitrag zur Klärung des psychischen Abhangigkeitspotentials von Tramadol. Arzneimittelforschung 28: 189–191

    PubMed  CAS  Google Scholar 

  574. Huskisson EC (1974) Measurement of pain. Lancet 9: 1127–1131

    Google Scholar 

  575. Ischia S, Luzzani A, Ischia A, Maffezzoli GF (1984) Bilateral percutaneous cervical cordotomy: immediate and long-term results in 36 patients with neoplastic disease. J Neurol Neurosurg Psychiatry 47: 141–147

    PubMed  CAS  Google Scholar 

  576. Jay SM, Elliott C, Varni JW (1986) Acute and chronic pain in adults and children with cancer. J Consult Clin Psychol 54/5: 601–607

    PubMed  CAS  Google Scholar 

  577. Jenkner FL (1988) Basic considerations I: Stimulation versus blocking. Schmerz Pain Douleur 9/3a: 140–164

    Google Scholar 

  578. Jensen MP, Karoly P, Braver S (1986) The measurement of clinical pain intensity. Pain 27: 117–126

    PubMed  CAS  Google Scholar 

  579. Jurna I (1984) Pharmakologische Grundlagen der Schmerztherapie. Dtsch Ärztebl 18: 1441

    Google Scholar 

  580. Kaiko RF, Kanner R, Foley KM et al. (1987) Cocaine and morphine interaction in acute and chronic pain. Pain 31: 35–45

    PubMed  CAS  Google Scholar 

  581. Kiss I (1987) Karzinomschmerzen. Springer. Berlin Heidelberg New York Tokyo (Anaesthesiologie und Intensivmedizin, Bd 196)

    Google Scholar 

  582. Klapetek J (1972) Das Depot-Analgetikum Develin retard bei chronischen Schmerzzuständen. Therapiewoche 22: 1402–1404

    Google Scholar 

  583. Kleeberg UR, Schreml W, Schönhöfer PS (1986) Schmerzbehandlung. In: Kompendium internistischer Onkologie, Teil 1. Springer, Berlin Heidelberg New York Tokyo, S 345–376

    Google Scholar 

  584. Klotz U (1987) Pharmakokinetik und Arzneimittelinteraktionen von antiphlogistisch and antipyretisch wirkenden Analgetika. In: Friedberg KD, Rüfer R (Hrsg) Antiphlogistisch und antipyretisch wirkende Analgetika. 2. Mannheimer Therapiegespräch. Fischer, Stuttgart S 11–16

    Google Scholar 

  585. Kocher R (1983) Psychopharmaka bei der Krebsschmerztherapie. Neurol Psychiatr 6 [Suppl l]: 29–35

    Google Scholar 

  586. Konturek SJ, Kwiecien N, Obtulowicz W et al. (1987) Double-blind placebo-controlled study on the effect of sucralfate on gastric biosynthesis of prostaglandin in normal and aspirintreated humans. In: Samuelsson B, Paoletti R, Ramwell PW (eds) Advances in prostaglandin, thromboxane and leukotriene research. Raven, New York, pp 311–314

    Google Scholar 

  587. Kossmann B, Ahnefeld FW, Bowdler I, Zimmermann M (1986) Schmerztherapie. Kohlhammer, Stuttgart

    Google Scholar 

  588. Krell R, Hanke M (1979) Klinische Prüfung der analgetischen Wirksamkeit von Valoron N im Vergleich zu Valoron bei Tumorschmerzen. Krankenhausarzt 52: 760–764

    Google Scholar 

  589. Krimmer H, Pfeiffer H, Arbogast R, Sprotte G (1986) Die kombinierte Infusionsanalgesie – Ein alternatives Konzept zur postoperativen Schmerztherapie. Chirurg 57: 327–329

    PubMed  CAS  Google Scholar 

  590. Kugler J, Spatz R (1984) Spektrum Antiepileptika. Aesopus, Zug

    Google Scholar 

  591. Kuttig H (1984) Radiotherapy of cancer pain. Recent Results Cancer Res 89: 191–194

    Google Scholar 

  592. Laitinen J (1976) Acupuncture and transcutaneous electric stimulation in the treatment of chronic sacrolumbalgia and ischialgia. Am J Chin Med 4: 169–175

    PubMed  CAS  Google Scholar 

  593. Lal A, Pandy K, Chandra P, Pandi SB (1973) Dipyrone for treatment of postoperative pain. Anaesthesia 28: 43

    PubMed  CAS  Google Scholar 

  594. Latasch L, Christ R (1986) Opiatrezeptoren. Anaesthesist 35: 55–65

    PubMed  CAS  Google Scholar 

  595. Lay A (1987) Nebenwirkungsprofile nicht-steroidaler Antiphlogistika nach den Berichten an die Arzneimittelkommission der Deutschen Ärzteschaft in den Jahrern 1961–1983. Inauguraldissertation, Universität Köln

    Google Scholar 

  596. Lehmann TR, Russell DW, Spratt KF et al. (1986) Efficacy of electroacupuncture and TENS in the rehabilitation of chronic low back pain patients. Pain 26: 277–290

    PubMed  CAS  Google Scholar 

  597. Levick S, Jacobs C, Loukas DF et al. (1988) Naproxen sodium in treatment of bone pain due to metastatic cancer. Pain 35: 253–258

    PubMed  CAS  Google Scholar 

  598. Levy MH (1982) Symptom control manual. In: Cassileth BR, Cassileth PA (eds) Clinical care of the terminal cancer patient. Lea & Febiger, Philadelphia, pp 214–262

    Google Scholar 

  599. Lintz W, Barth H, Osterloh G, Schmidt -Böthelt E (1986) Bioavilability of enteral tramadol formulations. Arzneimittelforschung 36: 1278–1283

    PubMed  CAS  Google Scholar 

  600. Lobato RD (1985) Intraventricular morphine for intractable pain associated with cancer. In: Pharmacia NU Tech (ed) Recent advances in intraspinal pain therapy. Upplands Grafiska, Uppsala, p 12

    Google Scholar 

  601. Lobato RD, Madrid JL, Fatela LV et al. (1984) Analgesic elicited by low-dose intraventricular morphine in terminal cancer patients. Pain [Suppl] 2: S342

    Google Scholar 

  602. Lobato RD, Madrid JL, Fatela LV et al. (1987) Intraventricular morphine for intractable cancer pain: rationale, methods, clinical results. Acta Anaesthesiol Scand 31 [Suppl 85]: 68–74

    Google Scholar 

  603. Loeser JD (1979) Dorsal column and peripheral stimulation forrelief of cancer pain. In: Bonica JJ, Ventafridda V (eds) Advances in pain research and therapy, vol 2. Raven, New York, pp 499–507

    Google Scholar 

  604. Lombardino JG (1985) Medicinical chemistry of acidid nonsteroidal antiinflammatory drugs. In: Lombardino JG (ed) Nonsteroidal antiinflammatory drugs. Wiley & Sons, New York, pp251–431

    Google Scholar 

  605. Londong W (1986) Anti-ulcer drugs in anti secretory doses for „cytoprotection‟ in arthritic patients? Klin Wochenschr 64 [Suppl VII]: 32–34

    PubMed  CAS  Google Scholar 

  606. Long DM (1982) Pain of visceral origin. In: Youmans JR (ed) Neurological surgery, vol 6. Saunders, Philadelphia, p 3627

    Google Scholar 

  607. Lorenz R, Grumme T, Herrmann HD et al. (1975) Percutaneous cordotomy. In: Penholz H (ed) Advances in neurosurgery, vol 3. Springer, Berlin Heidelberg New York

    Google Scholar 

  608. Lundstam SOA, Leissner KH, Wahllander LA, Kral JG (1982) Prostaglandin-synthetase inhibition with diclofenac sodium in treatment of renal colic: Comparison with use of a narcotic analgesic. Lancet I: 1096–1097

    Google Scholar 

  609. Lynn MD, Braunstein EM, Shapiro B (1987) Pheochromocytoma presenting as musculoskeletal pain from bone metastases. Skeletal Radiol 16: 552–555

    PubMed  CAS  Google Scholar 

  610. Madrid JL, Gozalo A, Fatela LV, Lobato RD (1984) Low dose cisternal morphine as a test for chronic intraventricular or intrathecal opiate therapy. Pain [Suppl] 2: S342

    Google Scholar 

  611. Magni G, Arsie D, De Leo D (1987) Antidepressants in the treatment of cancer pain. Pain 29: 347–353

    PubMed  CAS  Google Scholar 

  612. Maltebie AA, Cavenar JO (1977) Haloperidol and analgesia: case reports. Milit Med 142: 946–948

    Google Scholar 

  613. Martin WR (1979) History and development of mixed opioid agonists, partial agonists and antagonists. Br J Clin Pharmacol 7: 273 S-279S

    Google Scholar 

  614. Martin WR (1983) Pharmacology of opioids. Pharmacol Rev 35: 283–323

    PubMed  CAS  Google Scholar 

  615. McGivney WT, Grooks GM (1984) The care of patients with severe chronic pain in terminal illness. JAMA 251: 1182–1188

    PubMed  CAS  Google Scholar 

  616. McQuay HJ, Carroll D, Watts PG, Juniper RP, Moore RA (1989) Codeine 20 mg increases pain relief from ibuprofen 400 mg after third molar surgery. A repeat-dosing comparison of ibuprofen and an ibuprofen-codeine combination. Pain 37: 7–13

    PubMed  CAS  Google Scholar 

  617. Mertz DP (1986) Calcitonin bei Phantomschmerz. Dtsch Med Wochenschr 111: 1000

    PubMed  CAS  Google Scholar 

  618. Messer J, Reitman D, Sacks HS et al. (1983) Association of adrenocorticosteröid therapy and peptic ulcer disease. N Engl J Med 309: 21–24

    PubMed  CAS  Google Scholar 

  619. Meyer C, Kocher R, Felder M, Rosatti P (1985) Medikamentiise Schmerztherapie. Frage Antwort J 4: 3–17

    Google Scholar 

  620. Meynadier J, Chrubasik J, Dubar M, Wünsch E (1985) Intrathecal Somatostatin in terminally ill patients. A report of two cases. Pain 23: 9–12

    PubMed  CAS  Google Scholar 

  621. Miser AW, Dothage JA, Miser JS (1987) Continuous intravenous fentanyl for pain control in children and young adults with cancer. Clin J Pain 3: 152–157

    Google Scholar 

  622. Miser AW, Narang PK, Dothage JA et al. (1989) Transdermal fentanyl for pain control in patients with cancer. Pain 37/1: 15–21

    PubMed  CAS  Google Scholar 

  623. Moertel CG, Ahmann DL, Taylor WF, Schwartau N (1974) Relief of pain by oral medications. JAM A 229: 55–59

    CAS  Google Scholar 

  624. Moore DC (1979) Celiac (splanchnic) plexus block with alcohol for cancer pain of the upper intra-abdominal viscera. In: Bonica JJ, Ventafridda V (eds) Advances in pain research and therapy, vol 2. Raven, New York, pp 357–371

    Google Scholar 

  625. Moore DC (1979) Role of nerve block with neurolytic solutions for pelvic visceral cancer pain. In: Bonica JJ, Ventafridda V (eds) Advances in pain research and therapy, vol 2. Raven, New York, pp 593–596

    Google Scholar 

  626. Moore DK (1986) Continuous subcutaneous morphine for the control of severe chronic pain. Oncol Nurs Forum 13/4 [Suppl]: 52

    Google Scholar 

  627. Moore J, Dundee JW (1961) Alterations in response to somatic pain associated with anaesthesia. VII: The effects of nine phenothiazine derivates. Br J Anaesth 33: 422–431

    PubMed  CAS  Google Scholar 

  628. Motsch J (1986) Therapie des Schmerzes durch Nervenblockaden. Saari Ärztebl 6: 399–403

    Google Scholar 

  629. Motsch J, Schüder G, Bier B (1987) Use of portable pumps for continuous intrathecal narcotics infusion. Anaesthesist 36: 391

    Google Scholar 

  630. Müller H, Aigner K, Worm I, Lobisch M et al. (1984) Langzeit-Erfahrungen mit derkontinuierlichen periduralen Opiatanalgesie mittels implantierter Pumpen. Anaesthesist 33: 433–439

    PubMed  Google Scholar 

  631. Müller H, Aigner K, Zierski J (1985) Behandlung von Tumorschmerz mit Pumpsystemen zur rückenmarknahen Opiatapplikation. Dtsch Ärzteb 182/35: 2475–2484

    Google Scholar 

  632. Müller H, Börner U, Zierski J, Hempelmann G (1987) Intrathecal baclofen for treatment of tetanus-induced spasticity. Anaesthesiology 66/1: 76–79

    Google Scholar 

  633. Müller H, Lüben V, Zierski J, Hempelmann G (1988) Long term spinal opiate treatment. Acta Anaesthesiol Belg [Suppl 2] 39/2: 83–86

    PubMed  Google Scholar 

  634. Müller P, Dammann HG, Simon B (1986) Akute Schädigung der Magenschleimhaut durch Acetylsalicylsäure. Arzneimittelforschung 36 (I)/2: 265–268

    Google Scholar 

  635. Mullan S, Hosobuchi Y (1968) Respiratory hazards of high cervical percutaneous cordotomy. J Neurosurg 22: 291–297

    Google Scholar 

  636. Nehme AE, Warfield CA (1987) Cryoanalgesia: Freezing of peripheral nerves. Hosp Pract [Off] 22(1A): 71–72, 77

    CAS  Google Scholar 

  637. NN (1988) Gastrointestinale Effekte nichtsteroidaler Antirheumatika. Berichtzum Symposium „Arzneimittel-induzierte dyspeptische Beschwerden und peptische Läsionen im oberen Gastrointestinaltrakt, Aachen. Rheuma + Schmerz Entzündung 8/8: 46–47

    Google Scholar 

  638. Nyberg F, Almay BGL, Johansson F et al. (1988) Opioid peptides and substance p in cerebrospinal fluid - increased concentration after high frequency transcutaneous electrical nerve stimulation. Schmerz Pain Douleur 9/3a: 165–174

    Google Scholar 

  639. Obbens EAMT, Hill CS, Leavans ME et al. (1987) Intraventricular morphine administration for control of chronic cancer pain. Pain 28: 61–68

    PubMed  CAS  Google Scholar 

  640. Owitz S, Koppolu S (1983) Celiac plexus block: An overview. Mt Sinai J Med (NY) 50/6: 486–490

    CAS  Google Scholar 

  641. Pannuti F, Rossi AP, Jafelice G et al. (1982) Control of chronic pain in very advanced cancer patients with morphine hydrochloride administered by oral, rectal and sublingual route. Clinical report and preliminary results on morphine pharmacokinetics. Pharmacol Res Commun 14/4: 369–380

    PubMed  CAS  Google Scholar 

  642. Patel CV, Koppikar MG, Patel MS (1980) A double-blind comparison of dipyrone in the treatment of postoperative pain. CUff Med Res Opin 6: 624

    CAS  Google Scholar 

  643. Payne R (1987) Anatomy, physiology and neuropharmacology of cancer pain. Med Clin North Am 71: 153–167

    PubMed  CAS  Google Scholar 

  644. Penn RD, Kroin JS (1984) Intrathecal baclofen alleviates spinal cord spasticity. Lancet I: 1078

    Google Scholar 

  645. Pichlmaier H, Thielemann-Jonen I, Zech D (1988) Die palliative Behandlung von terminal Tumorkranken. Internist 29: 26–33

    PubMed  CAS  Google Scholar 

  646. Pohl S (1984) Hormonelle Analgesie mit Calcitonin. Schmerz 3: 93

    Google Scholar 

  647. Pollard M, Phyllis HL (1986) The beneficial effects of diphosphonate and piroxicam on the osteolytic and metastatic spread of rat prostate carcinoma cells. Prostate 8: 81–86

    PubMed  CAS  Google Scholar 

  648. Porges P, Zdrahal F (1985) Die intrathekale Alkoholneurolyse der unteren sakralen Wurzeln beim inoperablen Rektumkarzinom. Anaesthesist 34/11: 627–629

    PubMed  CAS  Google Scholar 

  649. Portenoy RK, Fole KM (1986) Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases. Pain 25: 171–186

    PubMed  CAS  Google Scholar 

  650. Probst C (1983) Neurochirurgische Möglichkeiten beim Karzinomschmerz. Schweiz Rundsch Med Prax 72/6: 171–176

    PubMed  CAS  Google Scholar 

  651. Ralston SH, Alzaid AA, Gardner MD, Boyle IT (1986) Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin. Br Med J 292: 1549–1550

    CAS  Google Scholar 

  652. Rawal N, Arnér S, Gustafsson LL, Allvin R (1987) Present state of extradural and intrathecal opioid analgesia in Sweden. Br J Anaesth 59: 791–799

    PubMed  CAS  Google Scholar 

  653. Regnard CFB, Davies A (1986) A guide to symptom relief in advanced cancer. Haigh & Hochland, Manchester

    Google Scholar 

  654. Reid W, Watt JK, Gray TG (1970) Phenol injection of the sympathetic chain. Br J Surg 57: 45–50

    PubMed  CAS  Google Scholar 

  655. Richardson PH, Vincent CA (1986) Acupuncture for the treatment of pain: a review of evaluative research. Pain 24: 15–40

    PubMed  CAS  Google Scholar 

  656. Richter HP, Schmidt K (1983) Neurochirurgische Behandlungsmöglichkeiten maligner Schmerzen. Chirurg 54: 789–794

    PubMed  CAS  Google Scholar 

  657. Robinson RG, Spicer JA, Preston DF et al. (1987) Treatment of metastatic bone pain with 89Strontium. Int J Rad Appllnstrum [B] 14/3: 219–22

    CAS  Google Scholar 

  658. Rogers AG (1987) The use of continuous subcutaneous infusion of narcotics in chronic cancer pain. J Pain Sympt Manag 2/3: 167–168

    CAS  Google Scholar 

  659. Rohdewald P, Neddermann E (1988) Dosisabhangigkeit der analgetischen Wirkung von Metamizol. Anaesthesist 37: 150–155

    PubMed  CAS  Google Scholar 

  660. Rosomoff HL (1969) Bilateral percutaneous cervical radiofrequency cordotomy. J Neurosurg 31: 41–46

    PubMed  CAS  Google Scholar 

  661. Rosomoff HL, Caroll F, Brown J, Sheptak P (1965) Percutaneous radiofrequency cervical cordotomy; Technique. J Neurosurg 23: 639–644

    PubMed  CAS  Google Scholar 

  662. Rumore NM, Schlichting DA (1986) Clinical efficacy of antihistaminics as analgesics. Pain 25: 7–22

    PubMed  CAS  Google Scholar 

  663. Ryan JR, Vargas R, Clay GA, McMahon FG (1987) Role of Misoprostol in reducing aspirin-induced gastrointestinal blood loss in arthritic patients. Am J Med 83 [Suppl 1A]: 41–44

    PubMed  CAS  Google Scholar 

  664. Sadove MS, Levin MJ, Rose RF, Schwartz L, Witt FW (1954) Chlorpromazine and narcotics in the management of pain of malignant lesions. AMA 155: 626–628

    CAS  Google Scholar 

  665. Säwe J (1986) High dose morphine and methadone in cancer patients. Clin Pharmacokin et 11: 87–106

    Google Scholar 

  666. Saris SC, Silver JM, Vieira JFS et al. (1986) Sacrococcygeal rhizotomy for perineal pain. Neurosurgery 18/5: 789–793

    Google Scholar 

  667. Schell HW (1972) Adrenal corticosteroid therapy in far-advanced cancer. Geriatrics 27: 131–141

    PubMed  CAS  Google Scholar 

  668. Schild H, Günther R, Hoffmann J, Goedecke R (1983) CT-gesteuerte Blockade des Plexus Coeliacus mit ventral em Zugang. Fortschr Röntgenstr 139/2: 202–205

    CAS  Google Scholar 

  669. Schroth HJ, Steinsträßer A, Berberich R, Kloss G (1985) Untersuchungen zur Wirksamkeit von Metamizol auf die Motilität der ableitenden Harnwege. In: Brune K, Lanz R (Hrsg) 100 Jahre Pyrazolone - Eine Bestandsaufnahme. Urban & Schwarzenberg, München, S 145–154

    Google Scholar 

  670. Schroth HJ, Garth H, Rupp St, Steinsträßer A (1986) Wirkung von Metamizol auf die Harnwegs-Motilität. Fortschr Med 104/18: 378–382

    Google Scholar 

  671. Schroth HJ, Garth H, Rupp S, Oberhausen E (1987) Wirkung von Metamizol auf die Kontraktilität der Gallenblase. Fortschr Med 105/7: 136–138

    PubMed  CAS  Google Scholar 

  672. Schüle-Hein K (1989) Palliative Strahlenbehandlung. In: Hankemeier U, Bowdler I, Zech D (Hrsg) Tumorschmerztherapie. Springer, Berlin Heidelberg New York Tokyo S. 102–123

    Google Scholar 

  673. Schug SA, Zech D, Dörr U (1988) The use of morphine in cancer pain - a german problem? J Pain Sympt Manag 3/3: 26

    Google Scholar 

  674. Schug SA, Zech D, Dörr U (1990) Cancer pain management according to WHO analgesic guidelines. J Pain Sympt Manag 5, 1: 27–32

    Google Scholar 

  675. Seemann H, Schug S, Zech D, Zimmermann M (1988) Kongreßbericht „Second International Congress on Cancer Pain‟ New York: Bewertung und Behandlung von Schmerzen bei Tumorpatienten. Med Klin 83/24: 846–853

    Google Scholar 

  676. Siegfried J (1988) Electrostimulation and neurosurgical measures in cancer pain. Recent Results Cancer Res 108: 28–32

    PubMed  CAS  Google Scholar 

  677. Siegfried J, Kühner A, Sturm V (1984) Neurosurgical treatment of cancer pain. In: Zimmermann M, Drings P, Wagner G (eds) Pain in the cancer patient. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  678. Siegmeth W (1986) Medikamentöse Rheumatherapie. In: Wörz R (Hrsg) Pharmakotherapie bei Schmerz. VHC, Weinheim, S 191–237

    Google Scholar 

  679. Silberstein EB, Williams C (1985) 89Strontium for the pain of osseous metastases. J Nuc1 Med 26/4: 345–348

    CAS  Google Scholar 

  680. Sjölund B, Terenius L, Eriksson M (1977) Increased CSF-Ievels of endorphins after electroacupuncture. Acta Physiol Scand 100: 382–384

    PubMed  Google Scholar 

  681. Sloan PA, Thirlwell M, Maroun J, Besner JG (1987) The pharmacokinetics of sustained-release morphine tablets. Anesth Analg 66: S 160

    Google Scholar 

  682. Spiegel D (1985) The use of hypnosis in controlling cancer pain. CA 35/4: 221–231

    PubMed  CAS  Google Scholar 

  683. Spiegel D, Bloom JR (1983) Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med 45: 333–339

    PubMed  CAS  Google Scholar 

  684. Spiegel D, Bloom JR, Yalom ID (1981) Group support for patients with metastatic cancer. A randomized outcome study. Arch Gen Psychiatry 38: 527–533

    PubMed  CAS  Google Scholar 

  685. Stammbaugh JE, Lane C (1983) Analgesic efficacy and pharmacokinetic evaluation of meperidine and hydroxyzine, alone and in combination. Cancer Invest 1: 111–117

    Google Scholar 

  686. Steude U (1983) Neurochirurgische Verfahren zur Behandlung von Krebsschmerzen. Arch Gynecol 235(1–4): 298–306

    PubMed  CAS  Google Scholar 

  687. Stillman MJ, Payne R, Foley KM (1988) Perineal pain in cancer patients. J Pain Sympt Manag 3: 21

    Google Scholar 

  688. Stoelting RK (1987) Pharmacology and physiology in anesthetic practice. Lippincott, Philadelphia

    Google Scholar 

  689. Su CF, Liu MY, Lin MT (1987) Intraventricular morphine produces pain relief, hypothermia, hyperglycaemia and increased prolactin and growth hormone in patients with cancer pain. J Neurol 235: 105–108

    PubMed  CAS  Google Scholar 

  690. Sunshine A, Laska E (1975) Nefopam and morphine in man. Clin Pharmacol Ther 18: 530–534

    PubMed  CAS  Google Scholar 

  691. Swerdlow M (1979) Subarachnoid and extradural neurolytic blocks. In: Bonica JJ, Ventafridda V (eds) Advances in pain research and therapy, vol 2. Raven, New York, pp 325–337

    Google Scholar 

  692. Swerdlow M (1987) Role of chemical neurolysis and local anaesthetic infiltration. In: Swerdlow M, Ventafridda V (eds) Cancer pain. MTP, Lancaster, pp 105–128

    Google Scholar 

  693. Swerdlow M, Cundill JG (1981) Anticonvulsant drugs used in the treatment ofiancinating pain. Anaesthesia 36: 1129–1132

    PubMed  CAS  Google Scholar 

  694. Sykes NP (1987) Pain control in terminal cancer. Int Disabil Stud 9: 33–37

    PubMed  CAS  Google Scholar 

  695. Szczeklik A, Czerniawska G, Nizankowska E (1985) Allergische und pseudoallergische Reaktionen auf Pyrazolonpräparate. In: Brune K, Lanz R (Hrsg) 100 Jahre Pyrazolone. Urban & Schwarzenberg, Miinchen, S 247–252

    Google Scholar 

  696. Takeda F (1988) Japan’s WHO cancer pain relief program. J Pain Sympt Manag 3/3: S27

    Google Scholar 

  697. Tempest SM (1982) Pain control in terminal illness. Pharmaceut J 229: 555–560

    Google Scholar 

  698. The International Agranulcytosis and Aplastic Anemia Study (1986) Risks of agranulocytosis and aplastic anemia, a first report of their relation to drug use with special reference to analgesics. JAMA 256: 1749–1757

    Google Scholar 

  699. Tigerstedt I, Sepponen J, Tammisto T, Turunen M (1977) Comparison of nefopam and pethidin in postoperative pain. Br J Anaesth 49: 1133–1138

    PubMed  CAS  Google Scholar 

  700. Tsai SK, Mok MS, Hung HL, Lippmann M (1988) Analgesic effect of intrathecal ketamine in primates. Anesth Analg 67: S234

    Google Scholar 

  701. Turnbull F (1979) The nature of pain that may accompany cancer of the lung. Pain 7: 371–375

    PubMed  CAS  Google Scholar 

  702. Turner JA, Chapman CR (1982) Psychological interventions for chronic pain: a critical review. I. Relaxation training and biofeedback. Pain 12: 1–21

    PubMed  CAS  Google Scholar 

  703. Turner JA, Chapman CR (1982) Psychological interventions for chronic pain: a critical review. II. Operant conditioning, hypnosis, and cognitive-behavioral therapy. Pain 12: 23–46

    PubMed  CAS  Google Scholar 

  704. Twycross RG (1978) The assessment of pain in advanced cancer. J Med Ethics 4: 112–116

    PubMed  CAS  Google Scholar 

  705. Twycross RG (1979) Non-narcotic, corticosteroids and psychotropic drugs. In: Twycross RG, Ventafridda V (eds) The continuing care of terminal cancer patients. Pergamon, New York pp 117–1134

    Google Scholar 

  706. Twycross RG (1980) Medical treatment of cancer pain. Bull Cancer 67: 209–216

    PubMed  CAS  Google Scholar 

  707. Twycross RG, Fairfield S (1982) Pain in far advanced cancer. Pain 14: 303–310

    PubMed  CAS  Google Scholar 

  708. Twycross RG, Lack SA (eds) (1983) Non-narcotic analgesics. In: Symptom control in far advanced cancer: Pain relief, Pitman, London, pp 117–148

    Google Scholar 

  709. Twycross RG, Lack SA (1983) Symptom control in far advanced cancer: Pain relief. Pitman, London

    Google Scholar 

  710. Twycross RG, Lack SA (1984) Therapeutics in terminal cancer. Pitman, London

    Google Scholar 

  711. Ventafridda V (1984) Use of analgesic drugs in cancer pain. In: Benedetti D (ed) Advances in pain research and therapy, vol 7. Raven, New York

    Google Scholar 

  712. Ventafridda V, Martino G (1976) Clinical evaluation of subarachnoid neurolytic blocks in intractable cancer pain. In: Bonica JJ, Albe-Fessard D (eds) Advances in pain research and therapy, vol 1. Raven, New York, pp 699–703

    Google Scholar 

  713. Ventafridda V, Olivieri E, Caraceni A et al. (1987) A retrospective study on the use of oral morphine in cancer pain. J Pain Sympt Manag 2: 77–81

    Google Scholar 

  714. Ventafridda V, Sganzerla EP, Fochi G, Pozzi G, Gordini G (1979) Transcutaneous nerve stimulation in cancer patients. In: Bonica JJ, Ventafridda V (eds) Advances in pain, research and therapy, vol 2. Raven, New York, pp 509–515

    Google Scholar 

  715. Ventafridda V, Tamburini M, Caraceni A et al. (1986) A validation study of the WHO method for cancer pain relief. Cancer 59: 850–856

    Google Scholar 

  716. Waldman SD, Coombs DW (1989) Selection of implantable narcotic delivery systems. Anesth Analg 68: 377–384

    PubMed  CAS  Google Scholar 

  717. Waldmeier PC (1987) Zur Pharmakologie der Antidepressiva beim chronischen Schmerz. In: Kocher R (Hrsg) Psychopharmaka bei chronischem Schmerz. Ciba-Geigy, Basel, S 56

    Google Scholar 

  718. Walker VA, Hoskin PJ, Hanks GW, White ID (1988) Evaluation of WHO analgesic guidelines for cancer pain in a hospital-based palliative care unit. J Pain Sympt Manag 3/3: 145–149

    CAS  Google Scholar 

  719. Walsh TD (1984) Oral morphine in chronic cancer pain. Pain 18: 1–11

    PubMed  CAS  Google Scholar 

  720. Watson PN, Evans RJ (1987) Intractable pain with lung cancer. Pain 29: 163–173

    PubMed  CAS  Google Scholar 

  721. Way EL, Young JM, Kemp JW (1965) Metabolism of heroin and its pharmacological implications. Bull Narc 17/1: 25–33

    CAS  Google Scholar 

  722. Westerling D, Andersson KE (1984) Rectal administration of morphine hydrogel: absorption and bioavailability in women. ActaAnaesthesiol Scand 28: 540–543

    CAS  Google Scholar 

  723. White JC, Sweet WH (1979) Anterolateral cordotomy: open versus closed, comparison of end results. Adv Pain Res Ther 3: 911–919

    Google Scholar 

  724. WHO (1986) Cancer pain relief. Genf

    Google Scholar 

  725. Wilder-Smith CH, Senn HJ (1987) Schmerzen bei Tumorpatienten. Arzneimitteltherapie 5: 139–151

    Google Scholar 

  726. Wörz R (1986) Karzinomschmerztherapie mit Arzneimitteln. In: Worz R (Hrsg) Pharmakotherapie bei Schmerz. VHC, Weinheim, S 273–290

    Google Scholar 

  727. Wörz R, Berlin J (1989) Behandlung chronischer Schmerzsyndrome mit Antidepressiva. Schmerz 3/1 : 1–7

    PubMed  Google Scholar 

  728. Xiang L, Bing Z, Shou-xin Z (1986) Relationship between electroacupuncture analgesia and descending pain inhibitory mechanism of nucleus raphe magnus. Pain 24: 383–396

    Google Scholar 

  729. Yaksh TL, Müller H (1982) Spinal opiate analgesia. Experimental and clinical studies. Springer, Berlin Heidelberg New York Tokyo (Anaesthesiologie und Intensivmedizin 144)

    Google Scholar 

  730. Yaksh TL, Rudy TA (1978) Narcotic analgetics: CNS-sites and mechanism of action. Pain 4: 299–359

    PubMed  CAS  Google Scholar 

  731. Zech D (1988) Ursache, Lokalisation und Behandlung der Schmerzen bei Patienten mit urologischen Malignomen. In: Hermann G, Heyer J, Engström P (Hrsg) Söldener Gespräche 1988, Wissenschaft und Forschung, Solingen, S 40–56

    Google Scholar 

  732. Zech D, Schug SA, Horsch M (1988) Therapiekompendium Tumorschmerz. Perimed, Erlangen

    Google Scholar 

  733. Zimmermann M (1984) Lokalisierte Eingriffe am Nervensystem zur Schmerzbehandlung. In: Zimmermann M, Handwerker O (Hrsg) Schmerz - Konzepte und arztliches Handeln. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  734. Zimmermann M (1984) Physiologie von Nozizeption und Schmerz. In: Zimmermann M, Handwerker O (Hrsg) Schmerz - Konzepte und ärztliches Handeln. Springer, Berlin Heidelberg New York Tokyo, S 1–42

    Google Scholar 

  735. Zoppi M, Hoigne R, Keller MF, Streit F, Hess T (1983) Blutdruckabfall unter Oipyron (Novaminsulfon-Natrium). Schweiz Med Wochenschr 113: 1768–1770

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. Pichlmaier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Spilker
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Germann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. H. Hackenbroch
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Rütt
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Said
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. W. Kruis
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R.-P. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. R. Zankovich
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M. Pfreundschuh
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. V. Diehl
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. I. Krüger
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. G. Friedmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. W. Gross-Fengels
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. H. O. Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. W. F. Jungi
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. I. Jonen-Thielemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. J. M. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. D. Zech
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. W. Buzello
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Chirurgische Klinik und Poliklinik der Universität zu Köln, Joseph-Stelzmann-Straße 9, W-5000, Köln 41, Deutschland

    Heinz Pichlmaier , Joachim Michael Müller  & Ingeborg Jonen-Thielemann ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pichlmaier, H. et al. (1991). Medizinische Behandlungsmaßnahmen. In: Pichlmaier, H., Müller, J.M., Jonen-Thielemann, I. (eds) Palliative Krebstherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75783-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-75783-9_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-75784-6

  • Online ISBN: 978-3-642-75783-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation